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Abstract
Tau filaments are the pathological hallmark of >20 neurodegenerative diseases
including Alzheimer’s disease, Pick’s disease, and progressive supranuclear palsy. In the
adult human brain, six isoforms of tau are expressed that differ by presence or absence of
the second of the four semiconserved repeats. As a consequence, half of the tau isoforms
have three repeats (3R tau), whereas the other half has four repeats (4R tau).
Site-directed spin labeling of recombinant tau in conjunction with electron
paramagnetic resonance spectroscopy was used to obtain structural insights into tau
filaments. The studies showed that the filaments of 4R tau and 3R tau share a highly
ordered core structure in the third repeat with parallel, in-register arrangement of βstrands. This structure in 3R and 4R is conserved regardless of whether full-length
isoforms (htau40 and htau23) or truncated constructs (K18 and K19) are used. When
mixed, 3R tau and 4R tau coassembled into heterogeneous filaments. Hence, these
findings indicate that there are at least three compositionally distinct types of filaments:
homogeneous 3R tau, homogeneous 4R tau, and heterogeneous 3R/4R tau.
In vitro experiments show that the seeded filament growth, a prerequisite for tau
spreading in tissue culture and brain, is crucially dependent on the isoform composition
of individual seeds. Seeds of 3R tau and 3R/4R tau recruit both types of isoforms whereas
seeds of 4R tau can recruit 4R tau, but not 3R tau, establishing an asymmetric barrier.
ii

Conformational templating of 4R tau onto 3R tau seeds eliminates this barrier, giving rise
to a new type of tau filament.
Conformational studies at the molecular level of tau filaments were done using
Double electron-electron resonance spectroscopy, which allows the determination of
distances between pairs of spin labels. These studies revealed structural differences
between filaments of 3R tau and 4R tau. Furthermore, they indicated that 4R tau assumed
the conformation of 3R tau when templated on 3R tau seeds. Our measurements have
also provided insights into the heterogeneity of tau filament structure.
Conformational differences due to variation in filament composition and seeding
properties of tau filaments have shown that they are structurally polymorphic in nature.
This structural polymorphism of tau filaments has widespread implications in
understanding and treatment of neurodegenerative diseases.
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Chapter One: Introduction
1.1 Tau protein
Tau protein was first isolated in 1975 from porcine brain and given the name tau
(τ) as it was found to induce tubule formation (Weingarten et al, 1975). Tau, a 55-62 kD
protein (Olmsted, 1986) is incorporated into growing microtubules as an integral
structural component and required for both initiation and elongation (Witman et al.,
1976) . Microtubules are a major component of the cytoskeletal system in eukaryotes
(Olmsted & Borisy, 1973) and studies have shown that in the absence of tau, purified
tubulin, a 6S dimer does not form microtubules (Olmsted & Borisy, 1973). Microtubules
are part of mitotic and meiotic component in cells and also major component of nerve
axons (Schmitt, 1968). Tau proteins apart from being an integral component of
microtubules in nerve axons, support the outgrowth of axons, modulate the transport of
vesicles and organelles along microtubules, serve as an anchor for enzymes and regulate
the dynamics of microtubules (Cassimeris & Spittle, 2001; Drubin & Kirschner, 1986;
Garcia & Cleveland, 2001; Weingarten et al., 1975).
Tau protein, also referred to as microtubule associated protein (MAPT), has an
unusual character compared to most other proteins. It is heat resistant and acid treatment
doesn’t result in it losing its function and also it has a low content of secondary structures
(Cleveland et al., 1977). These properties may be due to a high fraction of basic and
1

hydrophilic amino acid residues which resist the compact folding of most proteins. The
primary sequence of tau has a low hydrophobic content (mean hydrophobicity = 0.404)
and a net charge of +2 (Jeganathan et al., 2008). Biophysical studies have revealed that
tau is a prototypical “natively unfolded” protein (Schweers et al., 1994) . In the human
proteome these type of proteins have been classified as ‘‘natively unfolded’’ or
‘‘intrinsically unstructured proteins’’ [IUPs] (Dunker et al., 2008).
In the adult human brain, six isoforms of microtubule associated protein tau
(MAPT) are expressed. The MAPT gene consists of 16 exons and alternative mRNA
splicing gives rise to six tau isoforms (352-441 amino acids) (Goedert et al., 1988;
Goedert et al., 1989). The tau isoforms are classified based on the presence or absence of
29- or 58 amino acid insert in the N terminus and inclusion or exclusion of a 31-amino
acid repeat segment in the C terminus. Among the six isoforms, three isoforms have four
repeats (4R) and the other 3 isoforms have three repeats (3R) (Figure 1.1 A). In adult
brain, transcripts coding for 4R and 3R are expressed and in fetus only the smallest
isoform (htau 23) is expressed (Goedert et al., 1989; Goedert et al., 1989). The 3R and
the 4R regions are characterized by a Pro-Gly-Gly-Gly motif present in each repeat
(Goedert et al., 1988; Goedert et al., 1989). The amino acid sequence and the
corresponding DNA sequence of the full length tau isoform 4R htau40 are given in
Figure 1.2. The repeats carry out the major known biological function of tau: the binding
to and stabilization of microtubules (Butner & Kirschner, 1991; Goode & Feinstein,
1994). In disease conditions these tau monomers can aggregate to form filaments. These
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filaments belong to the major class of amyloid fibrils which are seen in various diseases
(Figure 1.3).

Figure 1.1: Bar diagrams of tau isoforms and constructs: (A) Tau isoforms are
defined by the presence or absence of two inserts in the N-terminal half (striped) and the
inclusion or exclusion of the second microtubule binding repeat in the C-terminal half
(marked as 2). Isoform sizes range from 352 amino acids (aa) to 441 amino acids and are
provided on the right. (B) The truncated constructs K18 and K19 contain the repeats (four
for K18 and three for K19) plus three additional residues at the C termini (Siddiqua &
Margittai, 2010).

3

Figure 1.2: Human tau40. The complete sequence of full length tau (htau40). The
highlighted sequence (yellow) is the second repeat.

4

For a polypeptide, its stable amyloid fibril state competes with its monomeric folded state
(when a folded state exists), or with other nonaggregated states (Tycko, 2011). The
relatively stable and remarkably protease resistant amyloid fibrils represent the end point
of the protein misfolding process. Tau filaments belong to the class of amyloid fibrils
whose formation is driven by hydrophobic interactions. The amyloid fibrils formed due
to these misfolding processes are implicated in many neurodegenerative diseases (Figure
1.3). Neurodegenerative diseases in which tau filaments are implicated are collectively
referred to as tauopathies (Lee, Goedert, & Trojanowski, 2001).

5

es of amyloid diseases. Tau and other proteins that are
Figure 1.3: Major classes
implicated in major amyloid diseases.

1.2 Tauopathies
The neurodegenerative diseases are characterized by distinct brain lesions that
have in common the formation of filamentous deposits of abnormal proteins.
proteins In
heterogeneous dementias and some movement disorders, it is characterized
neuropathologically by prominent intracellular accumulations of abnormal filaments
formed from the microtubule
rotubule associated protein tau (Table 1).
6

Table 1: Diseases in which tau inclusions have been described (M. Goedert &
Spillantini, 2011)
Alzheimer’s disease
Amyotrophic lateral sclerosis/parkinsonism-dementia complex
Argyrophilic grain disease
Chronic traumatic encephalopathy
Corticobasal degeneration
Diffuse neurofibrillary tangles with calcification
Down’s syndrome
Familial British dementia
Familial Danish dementia
Frontotemporal dementia and parkinsonism linked to chromosome 17
caused by MAPT mutations
Gerstmann–Sträussler–Scheinker disease
Guadeloupean parkinsonism
Mytotonic dystrophy
Niemann–Pick disease, type C
Non-Guamanian motor neuron disease with neurofibrillary tangles
Pantothenate kinase-associated neurodegeneration
Pick’s disease
Postencephalitic parkinsonism
Prion protein cerebral amyloid angiopathy
Progressive subcortical gliosis
Progressive supranuclear palsy
SLC9A6-related mental retardation
Subacute sclerosing panencephalitis
Tangle-only dementia
White matter tauopathy with globular glial inclusions
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Tau pathology is the hallmark of >20 neurodegenerative diseases, (Lee et al.,
2001). In frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP –
17) mutations in the tau gene have been linked to the disease (Goedert & Spillantini,
2011). The majority of tauopathies, however, develops sporadically.
Alzheimer’s disease (AD), a major dementia, is characterized by the presence of
two different types of deposits in the brain, senile plaques and neurofibrillary tangles
(NFTs). The main component of senile plaques is the β amyloid peptide whereas tau
protein is bundled into NFTs (Goedert & Spillantini, 2006; Grundke-Iqbal et al., 1986).
NFTs which consist of paired helical filaments (PHFs) and straight filaments are
composed predominantly of abnormally hyperphosphorylated tau proteins (Goedert et al.,
1988). Hyperphosphorylation is believed to be an early event in the pathway that leads
from soluble to insoluble and filamentous tau protein (Braak et al., 1994). However it is
unclear whether phosphorylation is sufficient for assembly of tau monomers into
filaments.
The advancing age of a person, generally 65 years or older, is a risk factor for AD
and other dementias, but the occurrence of neurodegenerative disease is not a normal part
of aging (alz.org). Neurodegenerative diseases have been shown not only to affect people
in their old age but also in their young age. Brain autopsies of players of football, hockey
and other games where the brain experiences increased incidences of concussion, the
presence of NFTs of tau protein have been reported. This disease has been classified as
Chronic Traumatic Encephalopathy. Autopsies of players as young as 21 years have
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shown the presence of NFTs in the brain (Los Angeles Times, 2011; McKee et al., 2009;
Omalu et al., 2011; Omalu et al., 2011; The New York Times, 2011).
1.3 Architecture of Tau Filaments
Straight filaments and PHFs (15-20 nm diameter) isolated from brain tissue have
a cross-β structure in which β-strands run perpendicular to the long fiber axis and are
spaced ~4.7 Å apart (Berriman et al., 2003) (Figure 1.4). This structural feature is a
common denominator of filaments belonging to the amyloid class (Sunde & Blake,
1997), which are self-assembled aggregates made from proteins with diverse amino acid
sequence (Sunde & Blake, 1998). In an amyloid fibril, two to six protofilaments (2-5 nm
in diameter) twist around each other to form a supramolecular structure (Serpell et al.,
2000). AFM measurements have shown that the fibrils form unbranched structures with
diameters ranging up to ~25nm. The fibrils themselves can again form large bundles.
The precursor proteins of these fibrils have no general sequence or 3- dimensional
(3D) structural homology in their native, soluble forms, but they all assemble into a
cross-β-fiber structure, with β-strands perpendicular and β-sheets parallel to the long fiber
axis.

9

Figure 1.4: Schematic structure of amyloid fiber. Arrangement of protein monomers
in β-pleated sheet structure in a protofilament either in parallel or anti parallel β-sheet
structure. The protofilaments twist together to form supramolecular structures called
fibrils.

When two or multiple sheets are present, they have a predominantly parallel inregister arrangement of β-strands and usually antiparallel arrangement of β-strands is
seen in peptides that form single β- sheets depending on the amino acid sequence
(Margittai & Langen, 2008).
The antiparallel β-strands are sometimes seen in aggregates formed by smaller
peptides, but the parallel in-register arrangement of β-strands in β-sheets is seen in most
of the amyloid fibrils. Tau filaments show parallel in-register arrangement of β-strands
(Margittai & Langen, 2004). Aggregates of other protein filaments of Aβ (Paravastu,
10

Petkova, & Tycko, 2006), IAPP (Jayasinghe & Langen, 2004), α-synuclein (Chen et.,
2007), β2-microglobulin (Ladner et al., 2010), HuPrP (Cobb et al., 2007) Rnq1 (Wickner
et al., 2008) also show parallel in-register arrangement.
Studies of β-amyloid fibrils have shown that fibrils with similar morphological
appearance can vary greatly in molecular design; and gross morphology and fine
structure need not be correlated (Petkova et al., 2005). Therefore, despite the shared
similarities described amongst tau filaments in the previous paragraph, they may be
different at the molecular level.
1.4 Importance of study of structural polymorphism in tau filaments
Even though tau filaments have been implicated in neurodegenerative diseases,
their role has been controversial (Brunden et al., 2008). In particular, it has been debated
whether filaments might have an altogether protective function by preventing individual
tau molecules from partitioning into toxic oligomers (Bretteville & Planel, 2008).
It has been suggested that the cytotoxicity of fibrils could be due to the number of
misfolded forms including non-fibrillar oligomers (Chiti & Dobson, 2006). The
importance of mature amyloid fibrils as etiological agents in AD and other amyloid
diseases, as opposed to nonfibrillar oligomers observed at earlier stages of peptide
incubation has been in dispute (Kayed et al., 2003; Lashuel et al., 2002). One principal
argument against a primary role for mature fibrils in AD has been the absence of a robust
correlation between the severity of neurological impairment and the extent of amyloid
deposition (Kirkitadze et al., 2002). Studies have shown that certain amyloid
morphologies may be more pathogenic than others in the affected organs of amyloid
11

diseases, which would weaken the correlation between disease symptoms and total
amyloid deposition (Petkova et al., 2005). As a result, the structural study of fibrils gains
importance.
There are various reasons why the study of structural polymorphism in tau
filaments is important. Studies in human, mouse and in vitro have revealed a direct link
between amyloid-β and tau in causing toxicity in Alzheimer’s disease (Hardy & Selkoe,
2002; Ittner & Götz, 2010). Tau protein is predominantly found in axons, and under some
physiological conditions, it has also been seen to localize in dendrites albeit in lower
amounts (Hirokawa, 1982). It mediates dendritic signaling and causes β-amyloid toxicity
in dendrites (Ittner & Götz, 2010). In tissue culture studies, transfer of tau filaments to
neighboring cells has been seen (Frost et al., 2009). Recent findings have suggested that
tau filaments could play an important role in the propagation of the misfolded state of tau
from one cell to the next (Lee et al., 2010). In addition, injections of insoluble tau into
mouse brain resulted in the spread of misfolding through different brain regions
(Clavaguera et al., 2009). Also it has been recently shown that tau pathology in vivo
could spread through synapses of nerve cells (Liu et al., 2012).
The above mentioned properties of tau filaments are reminiscent of those
observed in prion proteins (Prusiner, 1998). In the prion field it has been shown that the
same prion protein due to different conformational states could result in different
transmissible states (Prusiner, 1998). Although the overall evidence for prion-type
mechanisms in tauopathies is scarce, it has lent a new urgency and relevance to better
understand the structure of tau filaments.
12

There are currently 5.4 million cases of AD and related dementias in the U.S
population (Alzheimer's association, 2011). The annual healthcare cost of this aging
population is around $183 billion. It has been projected by 2050 that the number of
people with AD and other dementias would be 13.2 million and the health care cost
would be 1.1 trillion dollars. Therefore, neurodegenerative diseases are considered to be a
major health issue (alz.org, 2011).
For the past two decades, drug development efforts for the major
neurodegenerative disease AD have been focused on targets defined by the amyloid
cascade hypothesis (Hardy & Higgins, 1992; Karran et al., 2011) with disappointing
results. Tau-based strategies, in contrast have received little attention until recently,
despite the presence of extensive tau pathology. The discovery of mutations within the
tau gene that causes fronto-temporal dementia has demonstrated that tau dysfunction, in
the absence of amyloid pathology, is sufficient to cause neuronal loss and clinical
dementia (Medina, 2011). Investigation of the fundamentals of tau polymerization is
indispensable for identifying inhibitory conditions or compounds preventing formation of
PHFs which may allow the slowing down or even reverse the degeneration of neurons in
tauopathies (Andronesi et al., 2008). Considering all these, understanding the structural
polymorphism in tau filaments could be one of the starting points to come up with better
drugs in the future.
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My investigations into the structural polymorphism of tau filaments are organized
as follows:
Chapter 2 studies have tried to understand assembly of 3R and 4R tau isoforms in
filaments. Continuous wave electron paramagnetic resonance (CW EPR) spectroscopy in
combination with site directed spin labeling (SDSL) was used to study the assembly of
these isoforms.
Chapter 3 is related to the study of the recruitment of 3R and 4R tau isoforms into
filaments. For this purpose, an intrinsic fluorescence assay using the environment
sensitive dye acrylodan was developed.
Chapter 4 is related to the study of the structure of tau filaments at the residue
level using Double electron-electron resonance spectroscopy (DEER).

14

Chapter Two: Determination of Composition of Tau Filaments

2.1 Introduction
In the adult human brain, all six isoforms (Figure 1.1A) are present and the ratio
of 3R and 4R tau isoforms is ~one to one (Lee et al., 2001). Antisera raised against
synthetic peptides corresponding to different human tau isoforms have demonstrated that
multiple tau protein isoforms (both 3R and 4R) are incorporated into the neurofibrillary
tangles of AD (Goedert et al., 1989a; Goedert et al.,1992a; Greenberg et al.,1992). The
relative proportions of the tau isoforms observed in AD PHFs are similar to those that are
observed in normal adult human brain. Also different pathogenic mutations alter the
biochemical properties and stoichiometry of tau isoforms and this has been shown by
analysis of brains of FTDP-17 patients (Hong et al., 1998; Trojanowski & Lee, 1994). All
these studies led us to the question, whether the 3R and 4R isoforms segregate into
homogeneous filaments or coassemble to form heterogeneous filaments. To understand
this phenomenon, tau aggregation was studied in vitro.
2.1.1 Aggregation of tau filaments in vitro.
The exact mechanism responsible for assembly of soluble tau protein into
insoluble filaments in brain cells is not yet known. The monomeric tau proteins are
highly soluble and form a double hairpin loop, a paperclip like structure folded in the
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vicinity of the repeat region (Jeganathan et al., 2006), forming through transient
intramolecular contacts (Mukrasch et al., 2009). These interactions, together with the
overall positive charge of the protein, greatly inhibit aggregation. As a consequence a
negatively charged cofactor (heparin) is used to accelerate aggregation.
Heparin is a copolymer of alternating uronic acid and amino sugar residues, with
sulfated esters in various positions (Figure 2.1). The ionized carboxylate and sulfate
groups give it a high negative charge. The in vitro aggregation of non-phosphorylated tau
protein into filaments is based on the electrostatic interaction of negatively charged
heparin with the positively charged tau monomers (Calamai et al., 2006). The
characteristics of these in vitro assembled filaments closely resemble tau filaments from
AD brain (Goedert et al., 1996) . Other polyanions, for example, RNA, DNA, and
arachidonic acid have also been shown to cause aggregation of tau into filaments
(Calamai et al., 2006; Frost et al., 2009; Goedert et al., 1996). Studies have shown that
heparin becomes integrated into the rigid core region of the PHF, probably by providing
charge compensation for the lysine-rich stretches that form upon the stacking of the
repeat regions (Sibille et al., 2006). Also these polysulfonated sugars have been seen in
the plaques of many amyloid diseases (Strohmeyer et al., 2002). Binding of heparin to
Aβ, IAPP and α-synuclein is at a higher affinity than with their monomer states. These
observations indicate that recognition depends on the quaternary structure of the
aggregates and therefore heparin is seen in the rigid interiors of the amyloid fibrils
(Alexandrescu, 2005). This view is different from the observation made by some other
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researches that heparin is not associated with tau filaments, but is only required to
catalyze aggregation (Friedhoff et al., 1998; Jeganathan et al., 2008).

Figure 2.1: Partial heparin structure. (Sigmaaldrich.com)
When tau monomers self-aggregate into filaments, the microtubule binding repeat
(MTBR) region has shown to be protease resistant (Goedert et al., 1988; Novak et al.,
1993; Wischik et al., 1988), thus establishing itself to be part of the structured core. The
N- and C-terminal regions by contrast remain largely disordered, forming a fuzzy coat
(Wischik, et al., 1988). Charge and conformational changes are of uttermost importance
near the second (R2) and third (R3) MTBR that are thought to be involved directly in the
nucleation of the aggregation (Friedhoff et al., 1998). Therefore to accelerate aggregation
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of tau monomers into filaments, N and C termini are removed which is exemplified by
the 4R and 3R constructs K18 and K19 (Figure 1.1B) (Barghorn & Mandelkow, 2002).
2.1.2 Structure determination of tau filament.
Nuclear magnetic resonance spectroscopy and X-ray crystallography, which
have been used to determine protein structures at high resolution are inadequate to solve
structures of proteins with low solubility and those that do not form crystals. Analysis of
tau filaments, which are aggregates, has been challenging due to their large size and low
solubility. SDSL with CW EPR spectroscopy, which monitors structure at the backbone
level, fills part of this gap and has been very useful in studying the structures of filaments
(Hubbell et al., 1996; Huber et al., 2001; Margittai & Langen, 2004).
2.1.2.1 EPR spectroscopy.
EPR spectroscopy involves the study of energy differences due to the interaction
of an unpaired electron in the sample with a magnetic field, B0. This effect is called the
Zeeman Effect. The electron acts like a bar magnet when it is placed in a magnetic field
because of its magnetic moment. Since energies are quantized, a single unpaired electron
has only two allowed energy states. It has a state of lower energy; when the moment of
the electron, µ, is aligned with the magnetic field and a higher energy state when µ is
aligned against the magnetic field (Figure 2.2). The two states are designated by the
projection of the electron spin, ms, on the direction of the magnetic field. Because the
electron is a spin ½ particle, the parallel state has ms= -1/2 and the antiparallel state has
ms = +1/2. The difference between the energies of these two states is caused by the
interaction between the electron spin and the magnetic field.
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The energy, ∆E = hν is required to cause a transition between two spin states
∆    g BB0

and

B = eh/2me

Where g is the g-factor, µ B is the Bohr magneton which is the natural unit of the
electron’s magnetic moment, h is the Planck’s constant, e is the electron charge and me is
the mass of the electron and the change in spin state is ∆ms = ±1.

ms = +1/2

hν

∆E = hν = g µ B0

ms = -1/2

Magnetic Field (B0)

Figure 2.2: Zeeman energy level splitting. The energies of the two spin states of an
unpaired electron diverge when the magnetic field is scanned. The magnetic field for
which energy difference between the two electrons spin states is equal to hν for the
spectrometer, absorption of energy by the spins takes place which is called as resonance.
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In Figure 2.2, it is shown that in the absence of a magnetic field the two spin
states are degenerate and energies of the spin states diverge linearly as the magnetic field
is increased. To obtain an EPR spectrum, the electromagnetic radiation frequency
(microwave) is held constant and the magnetic field scanned. When the energy difference
between the two spins states matches the energy of the applied radiation, absorption
occurs (Figure 2.2). The field for resonance is not a unique “fingerprint” for
identification of a compound because spectra can be acquired at different microwave
frequencies (Eaton et al., 2009). However, the g value is independent of the magnetic
field.
2.1.2.2 Hyperfine interactions.
Additional information about the species that contains the unpaired electron can
be obtained from nuclear hyperfine interactions. The nuclei of the atoms in a molecule or
complex often have magnetic moments, which produce a local magnetic field at the
electron. The interaction between the electron and the nuclei is called the hyperfine
interaction. It gives a wealth of information about the sample such as the identity and
number of atoms in molecule or complex that have a magnetic moment; as well as the
electron spin density at those nuclei. When an electron spin interacts with a spin ½
nucleus such as hydrogen, the EPR absorption signal splits into two signals (Eaton et al.,
2009).
2.1.2.3 Spin label, EPR spectrum of Tau filaments.
For the study of protein structure and dynamics, SDSL in combination with EPR
has been systematically developed (Columbus & Hubbell, 2002; Hubbell et al., 1998;
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Hubbell et al., 1996; Hubbell et al., 2000a) and this has also proved to be an effective tool
in the investigation of tau filaments (Margittai & Langen, 2004; Margittai & Langen,
2006a) and other amyloid fibrils (Margittai & Langen, 2008). The spin label reports
faithfully on the conformation of the protein backbone regardless of the size of the
investigated species. Nitroxide scanning of a large set of spin labeled protein is done to
determine secondary structure (Hubbell et al., 1996). The introduction of the nitroxide
side chain is done by a common procedure in which cysteine – substitution mutagenesis
is followed by derivatization of the reactive cysteine with a sulfhydryl-selective nitroxide
reagent. The reactive native cysteines are first replaced by a suitable non-reactive amino
acid. Introduction of this spin label side chain at single sites in the structure results in a
remarkably small degree of structural perturbation (Hubbell et al., 1996). For our studies
nitroxide label, [1-oxyl-2,2,5,5-tetramethyl-∆3 – pyrroline-3-methyl]methanethiosulfonate (MTSL) was used (Figure 2.3) (Berliner et al., 1982). MTSL attached to the
cysteine residue has a free electron on the nitroxide group that can be detected in a
magnetic field. The four neighboring methyl groups in the C2 and C5 positions of the
pyrroline ring dramatically stabilize the radical, making MTSL a reliable reporter over
extended periods.
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Figure 2.3: Spin labeling of cysteine by nitroxide label. Derivatization of the –SH
group of cysteine side chain with MTSL radical by disulfide linkage.

EPR spectrum.
For filament studies, CW EPR measurements at X-band (9.2 – 9.9 GHz) are done,
where the incident wavelength is kept constant while the magnetic field is swept. The
absorption of electromagnetic radiation is influenced by the nuclear spin of the nitrogen
in MTSL resulting in three line EPR spectra. When an electron spin interacts with a spin
1 nucleus (I=1), such as 14N, then the number of hyperfine lines is three (2I+1=3) in the
absorption and its first derivative displays. The first derivatives are more commonly
depicted than the absorption spectra because of improvement in signal to noise ratio
(Eaton et al., 2009). The parameters that are typically extracted from CW EPR
measurements include mobility, accessibility, distance and polarity.
Mobility.
In the EPR spectrum, the line shape provides valuable information on the mobility
of the label and the local structure (Mchaourab et al., 1996). Line shapes reflect motion,
motional anisotropy, environmental polarity, and hydrogen bonding. A line shape denotes
an array of interacting parameters and cannot be reduced to a simple descriptive number
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reflecting local structure (Altenbach et al., 1990). When the nitroxide label is attached to
an unfolded site in the protein, it results in a spectrum with three sharp and narrowly
spaced lines with large amplitude (Figure 2.4 A). On the contrary, attachment to an
immobilized site results in broad lines, large separation of outer resonances and small
amplitude (Figure 2.4 B). When the label is attached to surface-exposed secondary
structures and tertiary contact sites, complex lineshapes are seen because of increase in
immobilized sites. The spectral features mentioned reflect the mobility of the label. These
features are quantified in terms of (1) spectral breadth (the inverse second moment <H-2>
and (2) inverse central linewidth ∆H0-1. These quantifications allow in categorizing
individual sites according to various backbone structures (Margittai et al., 2001; Margittai
& Langen, 2008; Mchaourab et al., 1996).
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Figure 2.4: EPR lineshapes. (A) Three line spectra with amplitudes are observed when
the spin labels are attached to mobile regions. (B) Broad spectra with small amplitudes
are seen when spin labels are attached to immobilized regions. The central linewidth is
given as ∆H0. For comparison, the spectrum in (B) is amplified 15-fold. Outer resonance
separations are given in gauss (G).
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Spin exchange.
The dipolar interactions in slow-motion regime (rigid lattice conditions) causes
line broadening of the EPR spectrum because of the proximity of two spin labels (0.7-2
nm). Apart from dipolar interactions, spin exchange due to orbital overlap between
multiple paramagnetic centers is also seen (Altenbach et al., 2001; Molin et al., 1980). In
this type of spin-spin interaction, the spectral features depend on the number of centers
and the spatial arrangement between them. However, spin exchange is not usually
observed in SDSL, as multiple spin label contacts are required. But in amyloid fibrils,
spin exchange plays an important role.
The appearance of spin exchange narrowed spectra is understood by observing the
line shapes for radicals. The EPR spectrum of a nitroxide label shows three sharp lines
with an intensity ratio of 1:1:1. Spin exchange results in collapse of the hyperfine lines
and narrowing of the spectra as a result of increase in exchange frequency (Figure 2.5).
The increased interactions between paramagnetic molecules are seen at high spin label
concentrations and reduction of distances between them.
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Figure 2.5: Spin Exchange and structural interpretation. Recombinant tau with a
single cysteine at position 310 attached with paramagnetic label MTSL. After fibril
formation in the presence of heparin and incubation for a period of 12 days, under
agitation, EPR measurements were taken. A single-line EPR spectrum is observed
because of spin exchange due to stacking of spin labels (yellow) in a parallel in-register
arrangement of β strands. The scan width for the spectrum is 150 G.

Biradicals and higher-order radicals with small molecular weights tumble rapidly
in solution and as a result averaging of dipolar interactions is seen (Hanson et al., 1996).
Crystals and amyloid fibrils do not tumble on EPR time scale and EPR spectra in these
systems show spin exchange phenomenon. The spin exchange frequency is > 108 s-1 and
it is also retained at lower temperatures (Margittai & Langen, 2004).
Correlation between exchange narrowing of EPR spectrum and tau filament
structure reported by SDSL.
The single-line EPR spectrum was first observed in tau filaments, a signature of
arrangement of β-strands in parallel and also in-register (Margittai & Langen, 2004). In
tau filaments, parallel in-register arrangement of β-strands is seen when identical amino
acids are stacked on top of each other along the length of the fiber axis (Figure 2.5). CW
EPR studies have also shown that filaments of β-amyloid (Torok et al., 2002), α synuclein (Chen et al., 2007), IAPP (Jayasinghe & Langen, 2004), β2 microglobulin
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(Ladner et al., 2010) and HuPrP (Cobb et al., 2007) also have parallel in-register
structure.
At the beginning of this project EPR investigations on the structure of tau
filaments had already been done for the 2nd repeat (Margittai & Langen, 2006a) and until
amino acid 320 in the 3rd repeat (Margittai & Langen, 2004). In continuation, the
complete structural study of the repeat region in 3R and 4R tau was done using SDSL and
CW EPR. After this, the same techniques were utilized to understand the composition of
tau filaments when mixtures 3R and 4R tau monomers form filaments. The findings of
this study have direct implications for the structures of filaments observed in AD and
other tauopathies.
2.2 Methods
2.2.1 Site directed mutagenesis.
DNA fragments containing full length tau (htau40) and fetal tau (htau23) were
generated by PCR amplification with primers containing NcoI and XhoI restriction sites.
The templates used for these reactions were htau40 in pRK172 (provided by Dr. Goedert
at the Medical Research Council Laboratory, Cambridge, UK) and htau23 in pBluescript
(provided by Dr. Matt Farrer at the Mayo Clinic, Jacksonville, FL). The fragments were
cloned into NcoI and XhoI restriction sites of prokaryotic expression vector pET-28b and
site directed mutagenesis of htau40 (C291S, C322S) and htau23 (C322S) were performed
to remove the two native cysteines (Margittai & Langen, 2004). The replacement of
cysteine residues with serine residues was shown not to cause any effect on the
morphology of tau filaments (Gamblin, et al. 2000). Subsequently the fragments of K18
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and K19 were generated in the second set of PCR amplification process from htau40 and
htau23 respectively and cloned into NcoI/XhoI restriction sites of pET-28b. Using the
QuikChange®II Site-Directed Mutagenesis Kit method from Strategene/Agilent
Technologies, site-directed mutagenesis was performed to introduce single cysteines in
cysteine free htau40 and htau23. The mutant primers for the PCR reaction were ordered
from IDT (Integrated DNA Technologies). For the PCR reaction setup, in the PCR tube
(0.2 ml, Fisherbrand), 5 µl of 10 X Reaction Buffer (provided in the strategene kit),
mutant plasmid 4 µl (5 ng/µL), dNTP (1 µl), PfuUltra High Fidelity DNA polymerase
(2.5 U/ µl), mutant primers forward and reverse (0.4 µM) were added and the reaction
volume was made up to 50 µl using H2O. The MJ MiniTM Personal Thermal Cycler (BIORAD) instrument was used to perform PCR reactions. The PCR temperature parameters
are provided in Table 2. For the PCR cycling, initial denaturation was done at 95°C. For
the annealing of the mutant primer to the DNA template, temperatures were varied from
55-60°C and for the elongation 68°C temperature was used. After PCR amplification, it
was important that the parent strand be removed. Parent strand which is methylated was
removed by digestion by DPN1 enzyme (10 U/ µl) which specifically recognizes the
methylated sites. The PCR product was incubated with the DPN1 enzyme (1µl) for 2 hrs
at 37°C for the digestion. For better transformation results, the salts in the PCR product
were removed by using a purification kit from Genscript (Quickclean 5M PCR
Purification kit) (Appendix B).
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Table 2
Polymerase Chain Reaction parameters used for tau mutagenesis
Segment

Number of cycles

Temperature(°C)

Time

1
2

1
17

95
95
55-60
68

45 seconds
45 seconds
1 minute
12 minutes

Transformation
Transformation of the mutant plasmid was done in XL1 Blue Supercompetent cell
lines (Strategene kit). For the transformation 14-ml BD Falcon Polypropylene round
bottom tubes were used. To 20 µl of XL1 Blue competent cell lines (Strategene kit), 2 µl
of the amplified DNA (PCR product) was added and incubated on ice for 30 minutes.
After 30 minutes, heat shock at 42°C was given to cells for 50 seconds. To the cells 800
µl of LB medium was added and incubated in a shaker for 45 minutes at 37°C. The cells
were plated onto kanamycin LB agar plates and incubated at 37°C for 24 hrs. The plates
were checked for colonies and stored at 4°C.
2.2.2 Plasmid purification, NcoI and XhoI digestion, DNA sequencing.
A single colony from the kanamycin agar plate was picked and added to 50 ml LB
medium, and 30 mM of kanamycin was added to it. The bacteria were allowed to grow
for 17 hrs, cells were pelleted and plasmid purification was done using Qiagen® Plasmid
Midiprep Kit (Appendix B).
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A Cary-100 Bio UV-Vis spectrophotometer from Varian was used to measure the
DNA concentration of the purified plasmid. The formula used was Unknown(µg/ml) =
A260 x 50 µg/ml X dilution factor, where the concentration of pure double stranded DNA,
50 µg/ml shows an absorbance at A260 = 1.0.
To check for the correct mutant tau gene size, digestion with NcoI and XhoI
restriction enzymes was performed. For this, 15 µl reaction volume was used. In the PCR
tubes, 1500 ng of mutant DNA was mixed with 1.5 µl 10 X BSA, 1.5 µl 10 X NEBuffer
2, 0.5 µl NcoI (10,000U/ml), XhoI (20,000U/ml) [ reagents from NEW ENGLAND
Biolabs®Inc.]. The samples were incubated at 37°C for 50 minutes. After the digest, the
samples were mixed with 4 µl sample buffer (BIO-RAD Nucleic Acid Sample Buffer 5X)
and agarose gel electrophoresis was carried out in the presence of 250 µl 1X TBE buffer
mixed with 10 µl of EtBr. For the gel, 1% agarose was used. For the full length tau
fragments, BIO-RAD EZ LoadTM 1 kb Molecular Ruler and for truncated versions, K18
and K19, BIO-RAD EZ LoadTM 100 bp Molecular Ruler was used to identify the
fragments. Agarose gels were viewed under UV light (BIORAD trans illuminator). Based
on the correct size of the DNA fragments, mutant plasmids were given for DNA
sequencing at University of Colorado Health Science (CU Cancer Center DNA
sequencing and Analysis service). Samples submitted to the sequencing facility had 2500
ng of plasmid DNA and 30 pmoles/µl primer concentration. For DNA sequencing,
primers T7 promoter (5’-TAATACGACTCACTATAGGG-3’) and T7 terminator (5’GCTAGTTATTGCTCAGCGG-3’) from IDT ReadyMade Primer were used.
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2.2.3 Expression and purification of tau proteins.
Expression of tau proteins was done in Escherichia coli (E.coli) strain BL21
(DE3). An overnight start culture was prepared of E.coli. To 50 ml of the LB broth, 30
mM kanamycin was added and a single colony of E.coli (having the required tau mutant)
was picked and added to the broth. The overnight start culture was incubated at 37°C for
16-17 hrs. To 1.5 L of autoclaved LB broth, 75 µM of kanamycin and 15 ml of the start
culture was added and incubated at 37°C in a shaker until the bacterial growth reached an
optical density between 0.8-1. After this, 1.0 mM of IPTG was added to each flask to
induce protein expression. The E.coli expression phase was for about 3.5 hrs. The
bacterial cells were spun down at 6000 x g for 20 minutes. The bacterial pellet was taken
up in resuspension buffer (20 mM Pipes, pH 6.5; 500 mM NaCl, 1 mM EDTA, 50 mM βmercaptoethanol) and kept at -80°C for further processing. Tau protein is extremely heat
stable (100°C, 5 minutes) (Weingarten et al., 1975). The heat stability and the high
isoelectric points of tau protein were utilized in the purification process (M. Margittai &
Langen, 2004).The cells were ruptured by heating at 80°C for 20 minutes and then
sonicated for 60 sec using Fisher scientific sonifier (150 T series) at amplitude 3.
The samples were immediately centrifuged at 15,000 x g for 30 minutes. To the
supernatant, ammonium sulfate (55-60% m/V) was added to precipitate the proteins.
After 1 h of salting out, the precipitate was centrifuged at 15,000 x g for 10 minutes.
Resuspension of the precipitate was carried out in H2O with 2 mM Dithiothreitol (DTT)
added to it. The solution was sonicated for 30 seconds, syringe filtered using Life
Sciences Acrodisc® Premium 25 mm Syringe filter with GxF/0.45 µm GHP membrane
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and further diluted with H2O (2 mM DTT) before loading onto the column to bring down
the conductivity of the solution. The instrument used for purification of tau protein was
AKTA design GE Healthcare Fast protein liquid chromatography (FPLC). Tau proteins
were purified using cation exchange chromatography based on their isoelectric points.
The buffers used for cation exchange chromatography were Buffer A and Buffer B with
20 mM Pipes (pH6.5) in them. The low pH of the buffer helps to increase the positive
charge of the tau protein. Proteins were loaded onto the Mono S column (GE Healthcare)
and eluted by applying NaCl gradient (Barghorn & Mandelkow, 2002). The program
used for purifying proteins by ion exchange and gel filtration is given in Appendix D.
Protein fractions were analyzed on SDS-PAGE with BIORAD® SDS-PAGE broad range
marker as the standard. To 6 µl of the elution fraction 2 µl of the 4X sample buffer (SB)
was added and loaded onto 15% SDS-PAGE gel for truncated tau and 12% SDS-PAGE
gel for full length tau. For the separation of the proteins a Mini PROTEAN II
electrophoresis chamber (BIORAD) was used. The gel was stained using Coomassie blue
and destained using Destain solution (Appendix A). The correct protein fractions were
pooled and then stored at -80°C after the addition of 5mM DTT. To further purify the tau
protein samples, gel filtration (Superdex 200 column) was carried out using Tris buffer
(pH 7.0). Protein fractions were collected and precipitated overnight at 4°C by adding an
equal volume of methanol with 5 mM DTT to the pooled fractions of full length tau. To
the truncated K18 and K19, three fold excess of acetone with 5 mM DTT was added. The
samples were pelleted and redistributed into equal aliquots. After centrifugation of the
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protein aliquots at 15,000 x g for 10 minutes, protein pellets were stored at -80°C in
methanol (2 mM DTT) for full length tau and acetone (2 mM DTT) for K18 and K19.
2.2.4 Spin labeling and filament assembly of tau proteins.
The organic solvent was removed from the stored protein pellets (4-6 mg). The
pellets were solubilized in 200 µl GndHCl and reacted with an ~10 fold molar excess of
either paramagnetic label MTSL or nonparamagnetic [1-acetyl-2,2,5,5-tetramethyl-∆3 –
pyrroline-3-methyl]methanethio-sulfonate (Gross et al., 1999). Both the chemicals were
purchased from Toronto Research Chemicals, Downsview, Canada. To attach the labels
to the single cysteine, proteins were incubated for 1 h at 25°C in the dark. The proteins
were passed over PD-10 desalting columns (GE Healthcare) using elution buffer (EB) to
remove all denaturant and unreacted labels. Protein concentration of htau40 and htau23
were measured in 6 M GndHCl by UV absorption at 276 nm (Appendix C) while K18
and K19 concentration measurements were done using BCA assay (Pierce) (Appendix
E).
To set up the proteins for filament formation, 20-30 µM of protein was mixed
with heparin (molecular mass ≈5,000 Da, Celsus, Cincinnati, OH) at a protein to heparin
molar ratio of 4:1. The full length and the truncated versions were incubated at 25°C
under constant stirring for 12 and 3 days, respectively. For all mixing experiments, final
protein concentrations were 50-60 µM and the protein: heparin molar ratio of 4:1 was
maintained. After filament formation, they were pelleted by ultracentrifugation at
100,000 x g for 30 minutes and finally washed with EB.
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2.2.5 Measurement of spin labeled filaments by EPR spectroscopy.
2.2.5.1 EPR measurement parameters.
Protein pellets were transferred into borosilicate capillaries (0.6-mm inner
diameter X 0.84 mm outer diameter, VitroCom, Mountain Lakes, NJ). Measurements
were carried out in a Bruker EMX spectrometer fitted with an ER 4119HS resonator. The
experimental parameters for taking the spectra were sweep width 150 G. The microwave
bridge parameters attenuator 12 dB, incident microwave power 12 milliwatts were used.
In the signal channel, the receiver gain was set at 5.02 X 103, modulation frequency at
100 kHz, modulation amplitude for filaments was set at 3 G and for monomers it was set
at 1.5 G. The modulation phase was set at 0 deg. The offset was 0%, time constant 81.92
msec, conversion time 20.48 msec, sweep time 41.49 sec, harmonic 1, resolution 2048
were set.
Data analysis was done using the software “A labview program for
multicomponent CW EPR spectra” by Christian Altenbach, University of California, Los
Angeles. Spectra were normalized to the same number of spins using double integration.
A minor background originating from <0.5% soluble tau was subtracted from all spectra.
2.2.6 Negative stain electron microscopy.
To view the tau filaments using electron microsope, carbon coated copper with
250 mesh grids (EM grid) (Electron Microscopy Sciences) were used. The EM grids were
placed for 40 seconds on 10 µl drops of tau filaments (3-4 µM). The EM grids were
removed and adsorbed onto the filter paper before placing them on 10 µl drops of 2%
uranyl acetate for 40 seconds. The grids were subsequently air-dried on filter paper for 10
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minutes. All images were taken with Phillips/FEI Tecnai-12 electron transmission
microscope operating at 80 keV equipped with a Gatan 2k x 2k CCD camera at
University of Colorado, School of Medicine, Cell and Developmental Biology
Department.
2.3 Results
2.3.1 Defining the stable ordered core in filaments of htau40.
Previous investigations on the conformation of tau filaments have revealed that
the third repeat of tau consists of a highly ordered core with parallel, in-registered
arrangement of β – strands (Margittai & Langen, 2004). These studies had been done up
to residue 320, which is the first half of the 3rd repeat. To look at the residues beyond 320
and to understand the structure, the naturally occurring cysteine at position 322 was
labeled with paramagnetic nitroxide label MTSL. The cross-linking of the nitroxide label
through a thiol linkage to the protein resulted in a new side chain R1 (Figure 2.6 A).
Before starting SDSL, the native cysteines were removed and replaced with serines to
maintain the selectivity of the approach (Todd et al., 1989).
When this labeled monomeric protein was measured, it produced an EPR
spectrum of three sharp lines (hyperfine splitting of EPR spectrum because of nitrogen
atom) characteristic of intrinsically disordered regions (Figure 2.6 B, left panel). After
the induction of tau monomers to form filaments with heparin and 12 days of incubation
under agitation at room temperature (25°C), EPR measurement showed a single line
spectrum (Figure 2.6 B, right panel). This spectrum is the signature feature for parallel,
in-register arrangement of β-strands (Margittai & Langen, 2008; Margittai & Langen,
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2004). The results showed that the ordered core region extends beyond the previously
published region (Margittai & Langen, 2004).The presence of filaments was confirmed
by negative stain electron microscopy (Figure 2.6 C).

Figure 2.6: Structural analysis of htau40 spin-labeled at position 322. (A) Labeling of
a cysteine in the protein with the paramagnetic label (1-oxy-2,2,5,5-tetramethyl-Dpyrroline-∆3-methyl)-methanethiosulfonate results in the side chain R1. (B) Monomeric
tau, labeled at position 322, produces a spectrum with three sharp lines (left)
characteristic for random structure (left insert). Formation of filaments results in a
spectrum with a single line indicative of crystal-type order with parallel, in-register
arrangement of β-strands (right insert). (C) Negative stain electron microscopy reveals
twisted filaments with 15-20 Å diameter. Bar = 100nm (Siddiqua & Margittai, 2010)
After seeing the parallel in-register structure at position 322, starting from
position 321 to 358, single cysteine residues, introduced by site-directed mutagenesis
were spin labeled. The CW spectra of labeled monomeric proteins showed three sharp
lines, which indicated a predominance of random structure (Figure 2.7). These findings
demonstrate that tau is an intrinsically disordered protein which is in good agreement
with previous studies (Cleveland et al., 1977; Schweers et al., 1994). After the addition of
heparin, filaments were allowed to form from tau monomers. When the CW EPR spectra
of the filaments were measured, significant changes in the line shape of the spectra were
observed. Based on the observed EPR spectra, the tau filament could be divided into two
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distinct regions (Figure 2.8 A). The first region (residues 321-336), which extends to the
end of repeat 3, gives rise to single-line spectra which makes this region a part of the
highly ordered core. The second region (residues 337-358) which is a part of the 4th
repeat produces spectra with single lines (e.g., 348), three lines (e.g., 346), or mixtures of
both single and three lines (e.g., 357).
Such spectral heterogeneity was previously observed in the 2nd repeat of the full
length tau (htau40) where single amino acid substitutions had caused a conformational
switch between stacked and disordered conformations. Based on this, it was concluded
that the 2nd repeat is less stable and an independent domain (Margittai & Langen, 2006a).
In line with the parallel, in-register arrangement of β-strands in the 2nd repeat,
introduction of β-branched residues promoted folding whereas the introduction of
charged residues prevented folding.
The 4th repeat showed a similar trend. The substitution of a charged amino acid,
for example, Asp-348 with cysteine and cross linking with the spin label resulted in a
single-line spectrum (representing ordered structure), whereas substitution of
hydrophobic amino acid (Val-350) produced a three-line spectrum (representing
disordered structure). Replacement of the amino acids with cysteines in the 3rd repeat
region inadvertently resulted in a single line spectrum. The signal amplitude increases
linearly with increasing amounts of mobile component (Margittai & Langen, 2006a;
Margittai & Langen, 2006b). An amplitude plot (Figure 2.8 B) shows low mobility for
residues in the 3rd repeat and varied mobility for residues in the 4th repeat. These data,
combined with previous observations (Margittai & Langen, 2004), reveal a stable, highly
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ordered core structure of the 3rd repeat which is flanked by marginally stable regions that
can switch between conformationally distinct states.

Figure 2.7: EPR spectra of htau40 monomers. Single cysteine mutants of htau40
(residues 321-358) were labeled with paramagnetic probe MTSL. All spectra were taken
at 150 G and normalized to the same number of spins. All spectra show three sharp lines,
which indicate a random coil structure (Siddiqua & Margittai, 2010).
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Figure 2.8: EPR analysis of spin-labeled htau40 filaments. (A) Residues 321-358 were
individually replaced by the side chain R1. All spectra were taken at 150 G and
normalized to the same number of spins. The dotted line between the left and middle
columns marks the boundary between repeats 3 and 4. (B) The amplitudes of all EPR
spectra are plotted against the respective residue numbers. All amplitudes are normalized
to spectrum F346R1, which has the highest amplitude (Siddiqua & Margittai, 2010).
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2.3.2 Preservation of core structure in htau23 and smaller tau fragments.
Investigations thus far have focused solely on the largest isoform htau40 which
has four microtubule binding repeats. To understand whether the fetal tau htau23 (three
microtubule binding repeats) has similar ordered core structure, six different cysteine
positions in the 3rd repeat (positions 309, 310, 311, 317, 322 and 326) were spin labeled.
All monomeric proteins produced EPR spectra with three sharp lines (Figure 2.9). This
observation is in good agreement with the current data which shows that soluble tau is
intrinsically disordered. The filament formation from monomeric tau was carried out by
addition of heparin and then incubating the sample for 12 days. Filaments were harvested
by centrifugation and transferred into EPR capillaries for measurement. EPR spectra of
the spin labels at the six investigated positions were all single line (Figure 2.10, left
column), indicating parallel, in-register arrangements of β-strands.
The smaller fragments of tau, K18 and K19 have been used in the past as valuable
models of tau aggregation (Barghorn & Mandelkow, 2002). To understand whether the
smaller fragments reveal similar structural arrangement, the same set of single cysteine
mutants were created and spin-labeled. The spin-labeled proteins in their monomeric
form showed three sharp lines in their EPR spectrum and the filaments showed a single
line spectrum (Figure 2.10, middle & right column). These results are similar to full
length tau isoforms. This indicates that the parallel, in-register arrangement of β-strands
is an intrinsic feature of the repeat region and maybe a common theme in all filaments of
isoforms and constructs containing the stable 3rd repeat.
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Figure 2.9: EPR spectra of htau23, K18 and K19 monomers. Single cysteine mutants
in the 3rd repeat were labeled with paramagnetic probe MTSL. All spectra were taken at
150 G and normalized to the same number of spins. All spectra show three sharp lines
which indicate a random coil structure (Siddiqua & Margittai, 2010).
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Figure 2.10: EPR spectra of filaments of htau23, K18, and K19. Residues in the third
repeat of htau23, K18, and K19 were replaced by cysteine attached to the paramagnetic
side chain R1. Spectra of all filaments were recorded at 150 G scan width and normalized
to the same number of spins (Siddiqua & Margittai, 2010).

2.3.3 3R and 4R tau combine to form heterogeneous filaments.
The above data shows that the filaments formed from 3R and 4R tau are
structurally similar. The question that arose from this was whether these constructs could
assemble into mixed filaments. To answer this question, in the first step, a paramagnetic
label at position 310 of K18 was attached. A nonparamagnetic label (which produces no
EPR signal) at position 310 of K19 was attached which resulted in a R1’ side chain
(Gross et al., 1999). The two proteins were subsequently mixed at different molar ratios
and heparin was added for fibrillization. After 3 days of incubation at 25°C under
agitation condition, all filaments were pelleted at 100,000 x g and transferred into EPR
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capillaries. At low spin concentration (10% R1), a three – line EPR spectrum was
observed (Figure 2.11 A, red trace) with outer peak separation of 68 G. Such a spectrum
is typical for an immobilized site with little interaction between spin labels (Margittai &
Langen, 2006a; Margittai & Langen, 2006b). At intermediate spin concentration (60%
R1), the spectrum broadened and the amplitude of the central peak decreased (Figure
2.11 A, green trace). These changes are due to dipolar interactions between labels, which
are effective at distances between 0.8 and 2.5 nm (Hubbell et al., 2000b). At high spin
concentration (100% R1), a single-line spectrum with increased amplitude was observed
(Figure 2.11 A, black trace). This spectrum is due to spin exchange between labels in
close contact (Margittai & Langen, 2008). The observation of a three-line EPR spectrum
at low spin concentration (10% R1) suggests that K18 had coassembled with K19.
Segregation into separate filaments can be excluded as this would have retained the
contacts between individual spin labels resulting in a single-line spectrum. To obtain a
more comprehensive picture of the coassembly between K18 and K19, a titration series
was performed in which the concentration of K18R1 was successively increased from 5
to 100%. The EPR spectra of filaments were taken and amplitudes of the central lines
were plotted as a function of the mole percent of K18R1 (Figure 2.11 B). The amplitude
changes are similar to those that had been previously observed in other spin dilution
experiments (Margittai & Langen, 2004; Margittai & Langen, 2008). Depending on the
type of spin interaction that dominates at a particular dilution, different amplitudes are
obtained: 1) large amplitudes for no interaction, 2) small amplitudes for dipolar coupling,
and 3) slightly elevated amplitudes, and loss of hyperfine splitting, for spin exchange
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(Figure 2.11 A). These changes occur gradually as the concentration of paramagnetic
label increases and the average distance between individual labels decrease. Various
spacing between labels in the differently composed filaments (Figure 2.11 B, insets I-III)
can explain these amplitude changes. An amplitude plot that is similar to the one depicted
here is obtained when instead of K18, K19 is attached to the paramagnetic label (Figure
2.12). This suggests that K18 and K19 have similar probabilities of integrating into the
filaments. To identify the core structure of heterogeneous filaments, equimolar ratios of
paramagnetically labeled K18 and K19 were mixed. A single-line EPR spectrum was
observed (Figure 2.11 C), suggesting a crystal-type order with parallel, in-register
arrangement of β-strands. Electron micrographs confirmed the presence of twisted and
bundled filaments (Figure 2.11 D). As expected, no amorphous aggregates were
observed for sample with single line EPR spectrum (Margittai & Langen, 2004).
In the adult brain full length versions of tau isoforms htau40 and htau23 are
present. To look at their ability to coassemble, the same labeling strategy of K18/K19
constructs was used. The htau40 was paramagnetically labeled while htau23 was labeled
with non paramagnetic label. The assembled filaments produced similar spectra to those
of the smaller constructs (Figure 2.11 E, compare with 2.11 A). Accordingly, the
amplitude plot obtained from a titration series of these isoforms revealed the same overall
features (Figure 2.11 F) as the one obtained for K18 and K19 (Figure 2.11 B and Figure
2.12). Furthermore, filaments formed from an equimolar mixture of paramagnetically
labeled htau40 and htau23 produced a single-line spectrum (Figure 2.11 G). The
presence of filaments and absence of amorphous aggregates was confirmed by negative
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stain electron microscopy (Figure 2.11 H). These results demonstrate that regardless of
construct size, 3R and 4R tau coassemble into heterogenous filaments with a core
containing parallel, in-register arranged β-strands (Margittai & Langen, 2006a).
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Figure 2.11: Coassembly of 3R and 4R tau. (A) EPR spectra of tau filaments
coassembled from K18R1 (paramagnetic) and K19R1’ (nonparamagnetic). The following
mole percentages were used: 1) 10% K18R1/90% K19R1’ (red trace), 2) 60%
K18R1/40% K19R1’(green trace), and 3) 100% K18R1 (black trace). In both constructs,
labels were attached to position 310. (B) The amplitudes of the central lines of the EPR
spectra in A together with those of additional dilutions are plotted as a function of the
mole percent of K18R1. Regions in the plot in which spectra are dominated by no spin
interactions, by dipolar coupling, or by spin exchange are interpreted in terms of different
β-strand combinations (insets I–III). K18R1 = green arrow, yellow dot; K19R1’ = red
arrow, black dot. (C) Spectrum of filaments formed from 50% K18R1 and 50% K19R1
(labels attached to position 310). The inset provides a structural interpretation. K18R1 =
green arrow, yellow dot; K19R1 = red arrow, yellow dot. (D) Electron micrograph of
heterogeneous filaments (K18R1/K19R1). Bar = 100 nm. (E) EPR spectra of filaments
formed from htau40R1 and htau23R1’ (all labels attached at position 310). Dilutions
have same color coding as in A. (F) Amplitudes of central lines from filaments formed at
different dilutions of htau40R1 and htau23R1’. (G) Spectrum of filaments formed from
50% htau40R1 and 50% htau23R1. All spectra were taken at 150 G and normalized to the
same number of spins. (H) Electron micrograph of htau40R1/htau23R1 filaments. Bar =
400 nm (Siddiqua & Margittai, 2010).
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Figure 2.12: Coassembly of K19R1 and K18R1’ into heterogeneous filaments.
Filaments were coassembled from K19R1 and K18R1’. EPR spectra were collected and
amplitudes of central lines were plotted as a function of the mole percent of K19R1 (red
trace). For comparison, the amplitudes from spectra of filaments formed from different
ratios of K18R1 and K19R1’ (see Figure 2.12B) are also plotted (black trace). The
amplitude derived from the spectrum of filament from K19R1/K18R1’ (10%/90%) is
arbitrarily set at 100 (Siddiqua & Margittai, 2010).
2.4 Discussion
Tau filaments are the pathological hallmark of numerous tauopathies. In most
diseases, filaments are composed of either 3R or 4R tau, but in AD, filaments contain all
isoforms. The isoform composition of tau filaments was determined twenty years ago
(Goedert & Spillantini, 2006; Greenberg et al., 1992) but it was not clear whether the 3R
and 4R isoforms in AD form homogeneous or heterogeneous filaments (Adams, et al.,
2010). This information is important as either aggregate could imply fundamentally
different mechanisms of tau fibrillization. This study involved obtaining molecular
insights into the structure of different tau filaments and to address the question of singlefilament composition. First, it was demonstrated that homogeneous filaments of both 3R
and 4R tau share a highly ordered core structure that coincides with the third repeat and is
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characterized by parallel in-register arrangement of β-strands. This conformation is
preserved regardless of whether full-length isoforms (htau40 and htau23) or smaller
constructs (K18 and K19) are used. Second, when 3R and 4R tau are present in the same
sample they coassemble into heterogenous filaments. This was seen for both the full
length tau and the truncated versions of tau. Because the heterogeneous filaments contain
the same ordered third repeat core structure as their homogeneous counterparts, the third
repeats of 3R and 4R tau must be able to replace each other. Together, these results
suggest that at least three fundamentally different types of tau filaments exist: 1)
filaments of 3R tau, 2) filaments of 4R tau, and 3) filaments of 3R/4R tau (Figure 2.13).
This classification is based on composition and places emphasis on the core-forming
repeat regions.

Figure 2.13: Types of tau filaments. 3R tau (red) and 4R tau (green) assemble
into at least three different types of filaments: 1) homogeneous filaments of
3R tau, 2) homogeneous filaments of 4R tau, and 3) heterogeneous filaments
of 3R and 4R tau. All filaments have in common a parallel, in-register
arrangement of β-strands in repeat 3 (Siddiqua & Margittai, 2010).
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Each 3R and 4R tau can represent three different isoforms that are defined by the
inclusion or exclusion of the two inserts in the N-terminal region (Figure 1.1). This
region is in the unstructured periphery of the filament and may not contribute to the
stable core (Wischik et al., 1988). It is evident from the experimental data that each
filament type can be further classified into subtypes composed of different isoforms at
various ratios. Dilution experiments have shown that 3R and 4R tau coassemble at
different ratios tested. As a consequence, a staggering number of filaments exist based on
composition alone. Despite a shared parallel, in-register arrangement of β-strands, all
three types of filaments must vary in conformation. This is because the second repeat of
4R tau contributes to the filament core (Li et al., 2002; Margittai & Langen, 2006a). Its
presence or absence results in different packing interactions for each filament type. For
example, in heterogeneous 3R/4R filaments, the second repeat cannot solely pack against
itself. Hence, 4R tau will assume different conformations depending on whether it is
incorporated into homogeneous or heterogeneous filaments. Conformational plasticity of
4R tau was seen when htau40 assumed different structures grown onto wild type
filaments as opposed to mutant filaments (Frost et al., 2009). Conformational plasticity is
a common property of amyloid proteins resulting in structurally distinct fibrils of
homogeneously composed proteins (Colby et al., 2009; Kodali, et al., 2010a; Paravastu et
al., 2008; Petkova et al., 2005; Tanaka et al., 2004a). It is likely that similar structural
polymorphisms exist for each type of tau filament. Compositional diversity and
conformational plasticity allow for a plethora of tau filament structures that may exceed
those of other amyloid fibrils.
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Ample experimental evidence suggests that phenotypic diversity in prion diseases
is encoded in different misfolded conformations of the same protein (Bessen & Marsh,
1994; Collinge et al., 1996; King & Diaz-Avalos, 2004; Tanaka et al., 2004a; Telling et
al., 1996). Fragmentation and growth properties of different fibrils have provided a
physical basis of how protein conformation could determine phenotype (Colby et al.,
2009; Tanaka et al., 2006). As pointed out before, the filaments in different tauopathies
have characteristic compositions of 3R and 4R tau. Filaments in Pick’s disease contain
3R tau. Filaments in progressive supranuclear palsy and corticobasal degeneration
contain 4R tau. Filaments in AD incorporate both 3R and 4R tau. Since 3R and 4R tau
coassemble in heterogeneous filaments, in AD, the filaments could be different from
those of 3R and 4R tauopathies. It was previously shown that filaments in AD contain
roughly equimolar ratios of 3R and 4R tau (Goedert et al., 1992a). This ratio reflects the
expression pattern of tau in the adult human brain (Goedert et al., 1989a; Goedert et al.,
1992a; Goode et al., 2000). Hence, the majority of individual filaments in AD brain may
be composed of evenly mixed 3R and 4R isoforms. However, because the expression
patterns of tau isoforms can vary between different neuronal subpopulations (Goedert et
al., 1989a), the specific composition of individual tau filaments could vary in a cellspecific manner. The free interchangeability of 3R and 4R tau allows for a broad
spectrum of heterogeneous filaments with diverse physical and biological properties.
Even though the repeat region in tau may determine the stability of filaments
(Jeganathan et al., 2008), the N-terminal inserts could still influence the interactions with
cellular components. Here, we demonstrate that 3R and 4R tau can coassemble into
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heterogeneous filaments, expanding the number of possible filament structures. If future
experiments corroborate interneuronal spreading of tau misfolding in a prion-like fashion
(Goedert et al., 2010), the large compositional and conformational diversity of tau
filaments could be an important contributor to the large phenotypic diversity of
tauopathies.
Apart from composition of 3R and 4R in tau filaments, the recruitment of 3R and
4R monomers into filaments could also cause conformational diversity. The next chapter
deals with the recruitment process of 3R and 4R into filaments and how it enhances the
conformational diversity of tau filaments.
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Chapter Three: Variations in Seeded Recruitment of 3R and 4R Tau Monomers
into Filaments

3.1 Introduction
As already mentioned, in the adult human brain 3R and 4R tau coexist at an
equimolar ratio (Goedert et al., 1989a) and this ratio is also reflected in the tau proteins
found in the filamentous inclusions of Alzheimer’s disease (Goedert et al., 1992a).
Abundant tau inclusions, in the absence of β-amyloid deposits, define Pick's disease,
progressive supranuclear palsy, corticobasal degeneration and other diseases. In contrast
to AD, filaments in progressive supranuclear palsy contain only 4R tau and filaments in
Pick’s disease contain only 3R tau (Buée & Delacourte, 1999). The molecular basis for
this difference in tau deposition in neurodegenerative diseases is not yet understood and
maybe understanding the recruitment of 3R and 4R tau monomers into filaments would
give a clue of why this difference in deposition of 3R and 4R is seen in various diseases.
3.1.1 Nucleated versus seeded tau filament formation.
In vitro assembly of tau filament formation (as that of other amyloid fibrils)
depends on the assembly of a critical nucleus onto which individual monomers can grow
(Figure 3.1). This nucleation event requires the cooperative interaction of a few
monomers to form oligomers which constitutes an initial lag phase in the formation of
filament. Also this nucleation event is concentration dependent. After the nucleation
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process, filament elongation is a fast process. The nucleation event marks the rate –
limiting step of fibril formation that can be circumvented by the addition of seeds
(Friedhoff et al., 1998; Nonaka et al., 2010). These in vitro aggregation features makes
this fibril assembly broadly similar to that of amyloid fiber aggregation in AD or other
aggregation processes in different neuronal disorders (Friedhoff et al., 1998).

Figure 3.1: Nucleated versus seeded formation of tau filaments (Not drawn to scale).

3.1.2 Spread of tau filaments.
There are various reasons for studying seeded in vitro reactions. Studies have
shown that filaments can transfer among neighboring cells in tissue culture (Frost et al.,
2009). The injection of brain extract from mutant P301S tau-expressing mice into the
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brain of transgenic wild-type tau-expressing animals was shown to induce the assembly
of wild-type human tau into filaments and the spread of pathology from the site of
injection to neighboring brain regions (Clavaguera et al., 2009). Also studies in mice
have shown that cognitive impairment becomes manifested when tau inclusions reach the
hippocampus from other regions of the brain. These abundant neocortical tau inclusions
and extracellular β-amyloid deposits found in mouse brain resembles the pathology seen
in AD (Clavaguera et al., 2009).
Recent studies have shown that the introduction of minute quantities of misfolded
tau filaments into tau-expressing cells rapidly recruits large amounts of soluble tau into
filamentous inclusions resembling NFTs. This efficient recruitment of tau monomers into
filaments suggests a “seeding”-recruitment process as a highly plausible mechanism
underlying NFT formation in vivo (Guo JL & Lee VM, 2011). The spontaneous uptake of
tau filaments into cells is most likely mediated by endocytosis, suggesting a potential
mechanism for the propagation of tau lesions in tauopathy brains (Guo JL & Lee VM,
2011).
Analysis of diseased brain tissues of humans have shown that in the disease
process neuronal tau inclusions first appear in the transentorhinal cortex, from where they
spread to the hippocampus and neocortex (Braak & Del Tredici, 2011). The spreading of
tau filaments is reminiscent of the (interneuronal) spreading of prions, which raises the
important question of whether prion-like mechanisms are responsible for tau
pathogenesis (Goedert et al., 2010; Prusiner, 1998). Prion diseases, unlike tauopathies,
are infectious. However, infectivity and interneuronal transmissibility of prions are
54

thought to be based on a single molecular principle: recruitment of monomeric proteins
onto the filament ends. Understanding this recruitment process for tau may provide
important molecular insights into the interneuronal spreading of tauopathies.
3.1.3 Study of recruitment of tau monomers into filaments
To study the recruitment of 3R and 4R tau monomers by seeds of tau filaments,
truncated versions of full length isoforms K18 and K19 were used (Figure 1.1). As the
aggregation kinetics of K18 and K19 is faster than that of full length htau40 and htau23,
the former constructs have been used as model systems for the aggregation of 3R and 4R
tau (Barghorn & Mandelkow, 2002).
3.1.3.1 Study of tau aggregation.
Previous studies on aggregation kinetics of proteins into amyloid fibrils have been
done using Thioflavin T assay (Khurana et al., 2005). This assay uses thioflavin T (ThT),
a thiobenzaldehyde dye which associates rapidly with aggregated fibrils of synthetic
peptides and gives rise to a new excitation (ex) (absorption) maximum at 450 nm and
enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of
the free dye (Levine III, 1993). This change is dependent on the aggregated state as
monomeric or dimeric peptides do not show this effect (Levine III, 1993). Also thioflavin
T, has been visualized bound along the fibrils using atomic force microscopy (Khurana et
al., 2005).
For our studies of kinetics of aggregation of tau monomers into filaments a
fluorescence assay using acrylodan was standardized. Acrylodan is an environment
sensitive dye and its behavior in solvents is explained in the following section.
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3.1.3.2 Monitoring of General solvent effects on Acrylodan by Fluorescence
Spectroscopy.

The general solvent effects on acrylodan fluorophore can be explained by a
Jablonski diagram (Figure 3.2).
Internal conversion and
vibrational relaxation
(10-12s)

S2
S1
µE

Less polar solvent

Solvent
relaxation
(10-10s)

More polar
solvent
(10-15s)
hνA
µG

(10-9s)
hνF
hν’

Figure 3.2: Jablonski diagram for fluorescence with solvent relaxation.

Fluorescence is the emission by a fluorophore of a photon from the lowest excited
state S1 to the ground state S0. Emission of a photon occurs with a certain energy E and
which can be observed at a certain wavelength λem. Because of the vibrational levels
fluorescence is seen at longer wavelengths than the first singlet absorption. Solvents also
have an effect on the position of the fluorescence band and many studies on
biomacromolecules have exploited this fact. One aspect of the solvent effect is the
General solvent effect which depends on the polarizability of the solvent, and increasing

56

the dielectric constant usually shifts the fluorescence to longer wavelength (Figure 3.2).
General solvent effects involve the interaction of the permanent dipole moment of the
molecule in both the ground and excited states with the reactive field induced in the
surrounding solvent.
The Franck-Condon principle states that during electronic transitions nuclei do
not move, but the electrons of the solvent molecules redistribute themselves around the
new excited state dipole. Also, because of the long lifetime of the excited state (10-8 s),
before the emission of the fluorophore, the solvent molecules reorient to their equilibrium
position around the excited state of the fluorophore (Figure 3.3).
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Figure 3.3: Dipole in a dielectric medium. The effects of electronic and orientation
reactions fields on the energy of a dipole in a dielectric medium, µ E > µ G, where µ E and
µ G are the excited and ground
ground-state
state dipole moments respectively of the electrons.
he dipole moments of the ground (µ G) and excited-state (µ E) and the reactive
The
fields around these dipoles describe the interaction of a fluorophore with solvent. Solvent
reorientation (RG and RE) and electronic motions define these fields (Figure
Figure 3.3). Ev
describes the energy levels of the fluorophore in the vapor state. The electronic
lectronic reaction
field which is induced by the excited st
state dipole causes the decrease of the absorption
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transition energy. This occurs because the electrons in the solvent follow the rapid change
in the electron distribution within the fluorophore as shown in Figure 3.3. On the
contrary, the orientation of the solvent molecules, during the absorption of light does not
change.
Tau filament aggregation was studied by attaching the acrylodan fluorophore to
the cysteine residue in the monomer. Since the acrylodan fluorescence emission is highly
sensitive to its local environment, when bound to a protein it exhibits changes in both
intensity and emission wavelength that reflect the degree of solvent exclusion and the
effective dielectric constant of the environment of the fluorophore (Hibbs et al., 2004;
Wearsch et al., 1998).
3.2 Methods
3.2.1 Site directed mutagenesis, protein expression and purification.
Site directed mutagenesis, protein expression and purification were done using the
protocols given in chapter 2 sections 2.2.1, 2.2.2 and 2.2.3.
3.2.2 Seed production.
In a 2 ml eppendorf vial, 1500 µl of 25 µM cysteine free K18 and K19 (or a
combination of 12.5 µM K18 and 12.5 µM K19) were mixed with a twofold molar excess
of heparin (50 µM) (average molecular mass of 5000 Da, Celsus, Cincinnati, OH) and
allowed to grow under agitation at room temperature (25°C) for 3 days. Subsequently, the
filaments (500 µl) were kept on ice for half an hour and then sonicated on ice for 20
seconds using Fisher Scientific Sonifier (150 T Series) at power setting 3. The seed
morphology was verified by negative stain electron microscopy (Figure 3.4). For
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multiple steps of seeded reactions, filament formation was allowed for 1 h and then they
were sonicated to produce seeds for the next reaction.

200 µm

Figure 3.4: Electron micrograph of filament seeds. The filament seeds are produced by
ultrasonic shearing of seeds.
3.2.3 Seeding assay and fluorescence detection.
3.2.3.1 Acrylodan assay.
The following mole percentages were used for all reactions: 2% acrylodan-labeled
tau, 98% cysteine-free tau. The final concentration of monomeric proteins K18 and K19
was 10 µM. For the fibrillization process 2 fold molar excess of heparin to tau was added.
Initiation of the seeding reactions was done by the addition of 3 mol% seeds.
Experiments that required multiple cycles of seeding and elongation contained higher
concentration of monomers (25 µM) and larger mole percentages of seeds (8%). After
one hour of fibrillization, each reaction was sonicated to produce seeds for the next
reaction cycle. The final seeding step in this multicycle procedure contained 3 mol%
seeds and 10 µM monomers. All reactions were monitored in a Fluorolog 3 system
(Horriba, Jobin). Temperatures were controlled at 37°C using a solid state Pelletier
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element. The fluorophore was excited at 360 nm and single emission spectra were
measured from 400-600 nm with excitation and emission slit widths set at 5 nm.
3.2.3.2 Thioflavin T seeding assay.
The filament formation was monitored by the change in ThT fluorescence upon
ThT binding to tau filaments (Maskevich et al., 2007; Naiki et al., 1989). Reactions were
carried out in a HEPES buffer (100 mM NaCl, 10 mM HEPES, pH 7.4) at 37°C, with
5µM ThT. Tau (10 µM K18 or K19) was pre-incubated for 5 min at 37°C, whereupon
reactions were initiated with 3 mol% of respective seeds. All reactions contained two fold
molar excess of heparin (average MW = 5000) to monomeric tau. Fluorescence was
measured using a Fluorolog 3 spectrofluorometer (Horiba Jobin Yvon), with the
excitation wavelength set at 440 nm and the emission wavelength set at 480 nm. The
excitation and emission slit widths were 5 nm.
3.2.4 Negative stain electron microscopy.
The method used here has already been mentioned in Chapter 2 section 2.2.6. The
tau filament concentration used was 10 µM.

3.3 Results
3.3.1 Seeds of 3R/4R Tau Nucleate the Formation of 3R and 4R Tau
filaments.

In the previous chapter we showed that the mixing of 3R and 4R tau monomers
causes them to coassemble into heterogeneous filaments rather than segregate into
separate filaments. Whether these coassembled filaments can effectively seed the
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propagation of individual 3R and 4R tau monomers is not known. For the studies,
acrylodan was cross-linked to a single cysteine (Figure 3.5 A) at position 310 in the third
repeat of K19. This site was chosen as it is located in the core of the filament (Andronesi
et al., 2008; Margittai & Langen, 2004) and as such is expected to have different polar
environments in monomers versus filaments. Furthermore, spin-labeling of the site had
no measurable effect on overall structure as shown in chapter 2. The reaction with
acrylodan resulted in a new side chain, henceforth referred to as A1. For the filament
formation, the labeled protein was mixed with a 50-fold molar excess of cysteine-free
K19. The fluorophore labeled sample was excited at 360 nm and the emission spectrum
was measured from 400 – 600 nm. The emission spectrum had a maximum at 523 nm
(Figure 3.5 B) which is characteristic of a solvent exposed site (Wearsch et al., 1998).
This result is in agreement with tau being an intrinsically disordered protein (Cleveland et
al., 1977; Schweers et al., 1994).
The addition of seeds that were produced by ultrasonic shearing of K18/K19
filaments and heparin (2 fold molar excess to the protein) initiated the aggregation of tau
monomers. Upon completion of the fibrillization process, the emission spectrum blue
shifted to 462 nm (Figure 3.5 B), indicating label exposure to a more hydrophobic
environment (Wearsch et al., 1998). The reciprocal of the wavelength for the emission
maximum was plotted as a function of time revealing elongation kinetics of K19 (Figure
3.5 C). Similarly, when K18 was allowed to grow on K18/K19 seeds the elongation
kinetics were similar to K19 on K18/K19 seeds. In the absence of seeds, aggregation of
neither K18 nor K19 on K18/K19 seeds was seen. The presence of filaments in the
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seeded reactions was confirmed by negative stain electron microscopy (Figure 3.5 D, E).
Together, these findings suggest that the filaments of 3R/4R tau serve as seeds for the
formation of 3R and 4R tau filaments.
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Figure 3.5: Seeds of K18/K19 effectively template growth of K18 and K19. (A)
Scheme of acrylodan labeling of cysteine side chain. (B) Addition of 3% K18/K19 seeds
to a mixture of monomers of 98% K19 and 2% K19_310A1 (total concentration: 10 µM)
results in a time-dependent blue shift in the emission maximum. Traces from right to left
represent reactions after 0, 0.5, 5, 10, and 80 min. Excitation: 360 nm, Emission: 400600nm. (C) The reciprocal of wavelength plotted as a function of time reveals the
progression of K19 (red trace) and K18 (black trace) aggregation. In the absence of seeds
no changes are observed. Values represent mean ±s.d (n = 3 experiments). (D, E)
Electron micrographs of K18 and K19 filaments produced through K18/K19 seeded
reactions (Dinkel et al., 2011).
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3.3.2 Cross-seeding barrier prevents growth of 3R tau onto 4R tau seeds.
When compared to K18, K19 lacks the 2nd microtubule binding repeat (Figure
1.1B). To determine whether this variation affects the filament conformation, the seeding
properties of K18 and K19 filaments were tested. In the first set of experiments, the
elongation kinetics of K18 and K19 on K18 seeds was monitored. The acrylodan
fluorophore was attached to position 310 of both K18 and K19 to report the fibrillization
process. A 50-fold molar excess of K18 and K19 cysteine-free protein was mixed with
K18_310 A1 and K19_310 A1 respectively. The results showed that K18 grew on K18
seeds while K19 did not grow on K18 seeds (Figure 3.6A). An increase in the
concentration of seeds by 3- or 5-fold did not lead to incorporation of K19 monomers on
K18 seeds, which indicates a robust conformational barrier (Figure 3.7 A). The
attachment of label to different positions of the K19 was checked to see whether this
conformational barrier was due to labeling at position 310 (Figure 3.7 B). These labeled
K19 monomers (317, 322) also failed to form filaments. Electron micrographs confirmed
this seeding behavior as filaments were observed for K18 (Figure 3.6 B), but not for K19
(Figure 3.6 C). In the next step, seeds from K19 were produced, and K18 and K19
allowed to grow on them. Both K18 and K19 grew on K19 seeds but the incorporation of
K19 monomers was markedly more efficient (Figure 3.6 D). The filamentous nature of
the aggregates was confirmed by electron microscopy (Figure 3.6 E, F). In order to
verify the seeding properties of K18 and K19 independently, all experiments were carried
out using an extrinsic thioflavin T based assay (Figure 3.8 A, B). The same asymmetric
barrier was observed. Furthermore, replacement of the truncated monomers with full65

length versions of tau (htau23 and htau40) produced similar seeding characteristics, albeit
with slower kinetics (Figure 3.9 A, B). Combined, these data suggest that conformational
differences between filaments of 3R and 4R tau allow growth of 4R tau onto 3R tau seeds
but prevent the growth of 3R tau on 4R tau seeds.

Figure 3.6: Asymmetric barrier for K18 and K19 cross-seeding. (A) Aggregation of
K18 monomers (98% K18, 2% K18_310A1) and K19 monomers (98% K19, 2%
K19_310A1) in the presence of 3% K18 seeds. (B) Electron micrograph of K18 filaments
seeded with K18. (C) Electron micrograph of K19 grown onto K18 seeds. (D)
Aggregation of K19 monomers (98% K19, 2% K19_310A1) and K18 monomers (98%
K18, 2% K18_310A1) in the presence of 3% K19 seeds. (E) Electron micrograph of K18
grown onto K19 seeds. (F) Electron micrograph of K19 grown onto K19 seeds. Protein
concentrations were 10 µM. All values represent mean ±s.d. (n = experiments) (Dinkel et
al., 2011).
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Figure 3.7: Robust asymmetric barrier for K18 and K19 cross-seeding. (A) A robust
barrier prevents growth of K19 monomers onto K18 seeds. Circles = 9% seeds, diamonds
= 15% seeds. Growth of K18 monomers onto 3% K18 seeds (triangles) is reproduced
from figure 3.6 A and shown for comparison. In all samples acrylodan is attached to
position 310. (B) K19 aggregation monitored through acrylodan-labeled constructs
K19_317A1 (circles) and K19_322A1 (squares) indicates that regardless of the position
that is labeled, K19 does not grow onto K18 seeds. Growth of K18 onto K18 seeds
(triangles) is depicted for comparison. In all cases 3% seeds are added to 10 µM
monomers (Dinkel et al., 2011).
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A

B

Figure 3.8: Seeded filament growth monitored with Thioflavin T (5 µM).
(A) Changes in fluorescence intensity indicate that K18 monomers grow onto K18 seeds,
but K19 monomers do not. (B) ThT fluorescence reveals growth of K19 monomers onto
K19 seeds and reduced growth of K18 monomers onto K19 seeds. In all ThT
experiments, 3% seeds are added to 10 µM monomers. All values in A, B represent mean
± s.d. (n = 3 experiments) (Dinkel et al., 2011).
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B

Figure 3.9: Full length aggregation kinetics of htau40 and htau23. (A) Aggregation of
htau23 monomers (98% htau23, 2%htau23_310A1) in the presence of 8% K19 seeds or
8% K18 seeds. (B) Aggregation of htau40 monomers (98% htau40, 2% htau40_310A1)
seeded by addition of 8% K18 seeds or 8% K19 seeds. Monomer concentrations are
20µM. All values in A, B represent mean ± s.d. (n = 3 experiments) (Dinkel et al., 2011).
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3.3.3 Cross-seeding gives rise to a new type of 4R tau filament.
The observation that 4R tau can grow onto 3R tau seeds raised the question of
whether the resulting filaments have the ability to seed 3R tau. Such a property would be
expected if the monomers of 4R tau assumed the conformation of the seeds of 3R tau. In
order to address this question, a three step seeding experiment was carried out (Figure
3.10 A). In the first step K18 monomers were grown on K19 seeds. In the second step
three cycles of seeding and elongation produced an enriched population of K18 filaments.
In the third step seeds of these K18 filaments were added to K19 monomers. Remarkably,
the K18 seeds had the ability to seed the formation of K19 filaments (Figure 3.10 B, top
trace). As a result of the multistep procedure the concentration of K19 seeds was reduced
from 2.0 X 10-6M in the first reaction to 3.1 X 10-11M in the final reaction. At this final
seed concentration K19 does not accelerate aggregation, therefore the growth of K19
monomers was not affected by any residual K19 seeds. The presence of filaments was
confirmed by EM (Figure 3.10 C). Importantly, when the initial seeds in the multistep
seeding procedure were composed of K18, seeding of K19 in the final step did not occur
(Figure 3.10 B, bottom trace). Corresponding results were obtained when the full length
tau was used in the final elongation step (Figure 3.11 A, B). These observations are
important as they demonstrate that the same protein, K18, can produce filaments with
different seeding properties, depending on the initial template, and furthermore that these
properties can be propagated over multiple generations.

70

Figure 3.10: Tau filament diversification. (A) Experimental design of multicycle
seeding reactions. Each time seeds from the previous reactions were used to form new
filaments. (B) Aggregation of K19 monomers (98% K19, 2% K19_310A1) in the
presence of 3% K18 seeds (last step in A) monitored as a change in the reciprocal of
emission wavelength over time (top trace). When instead of K19 seeds K18 seeds were
present in the initial step, no aggregation was seen (bottom trace). (C) Electron
micrograph representing the end point of the top trace in (B) (Dinkel et al., 2011).
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Figure 3.11: Tau filament diversification in full length tau. A multi-cycle seeding
procedure as outlined in Fig. 3.10 A is used with the only difference that seeds (8 mol %)
in final reaction are added to htau23 (20 µM) instead of K19. (A) Aggregation of this
reaction (98% htau23, 2% htau23_310A1) is monitored as a change in reciprocal
emission wavelength over time (red). When initial seeds in this five-step procedure are
K18 and not K19 filaments, aggregation does not occur (black trace). (B) Electron
micrograph representing the end point of the red trace in A (Dinkel et al., 2011).

3.4 Discussion
The identification of three compositionally distinct types of tau filaments that
share a common core with parallel, in-register arrangement raised the question of whether
these filaments could be conformationally distinct. In filaments, variations in packing
interactions could impart different biophysical properties to them. To identify differences
between the three types of filaments their seeding characteristics were studied. Recent
evidence suggests that caspase-cleaved fragments (De Calignon et al., 2010), and other
truncated forms of tau (Wang et al., 2007), may play a critical role in the initiation of
filament formation. These smaller forms accelerated kinetics and therefore seeds may
serve as templates onto which full-length isoforms bind (De Calignon et al., 2010; Wang
et al., 2007). For seeds, the constructs K18 and K19 were chosen, which are truncated
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versions of tau that contain the core-forming repeat region (Figure 1.1B). The following
key observations were made irrespective of whether truncated (K18 and K19) or fulllength versions of tau (htau23 and htau40) were used for filament growth (summarized in
Figure 3.12): First, seeds of 3R tau and 3R/4R tau recruit both types of isoforms. Second,
seeds of 4R tau recruit 4R tau and 3R/4R tau, but not 3R tau, establishing an asymmetric
barrier. Third, conformational templating of 4R tau onto 3R tau seeds abolishes this
barrier giving rise to a new type of tau filament. These results indicate the existence of at
least four conformationally distinct types of filaments.

Figure 3.12: Templated filament growth of tau. Monomers of 3R and 4R tau (top) can
grow only on the ends of 3R (blue), 3R/4R (yellow) and 4R filaments (green and pink) if
their sequence is compatible with the conformation of the seed (arrows). Structural
incompatibility gives rise to a seeding barrier (crossed out arrow) (Dinkel et al., 2011).

Conformationally distinct fibrils are a hallmark of prions and are thought to be the
basis for strain (or phenotype) variations in mammals (Colby et al., 2009; Legname et al.,
2006) and yeast (King & Diaz-Avalos, 2004; Tanaka et al., 2004a). Strain identity is
thought to be maintained by imprinting the conformation of the prion fibril onto the
soluble prion proteins via seeded conversion (Castilla et al., 2008; Jones & Surewicz,
2005). Prion proteins that vary in sequence may also be recruited giving rise to the
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transmission of prions from one species to another or, in the case of polymorphisms, the
transmission within species (Collinge, 2001). This process can lead to the emergence of
new strains as exemplified by the appearance of variant Creutzfeld Jacob’s disease,
which has been linked to the transmission of bovine prions to humans (Collinge et al.,
1996). If the primary structure of the variant is incompatible with the conformation of the
seed, a transmission barrier occurs. The seeding barrier that prohibits 3R tau from
growing onto 4R tau seeds is reminiscent of such a barrier, suggesting that the primary
structure of 3R tau is incompatible with the conformation of 4R tau seeds. The primary
structure of 4R tau, however, is compatible with the conformation of 3R tau seeds,
leading to the emergence of a new type of filament. An asymmetry in seeding specificity,
similar to that observed for 3R and 4R tau, has been described for the tau disease mutant
P301L (Aoyagi et al., 2007). While the seeds of this mutant recruited its respective
monomers, wild type monomers were not recruited. Wild type seeds, on the other hand,
were able to recruit both mutant and wild type tau. Whether P301L that had been grown
onto the wild type seeds resembled a new type of filament that was able to seed wild type
tau has not been addressed. Regardless, these findings demonstrate that the coexistence of
different tau isoforms and the presence of tau mutants could have intricate effects on the
propagation.
On the basis of their seeding properties, we have identified four conformationally
distinct types of filaments (Figure 3.12). It is likely that additional types of filaments
exist. Previous experiments have demonstrated that 4R tau can adopt different
conformations when grown onto distinct seeds (Frost et al., 2009; Colby et al., 2009),
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revealing a structural plasticity of tau akin to that of other amyloid proteins (Colby et al.,
2009; Kodali et al., 2010a; Paravastu et al., 2009; Petkova et al., 2005; Tanaka et al.,
2004a). The in vitro conditions that were used for filament formation arguably do not
recapitulate the complex biochemical environment in the human brain. Cofactors,
chaperones, and post-translational modifications could affect filament formation in a celldependent manner. In fact, in the case of prions it has been shown that different cell lines
can favor different prion strains (Mahal et al., 2007) and that selective pressures can
cause the amplification of new strains and the disappearance of old ones (Li et al., 2010).
Despite their deficiencies, our in vitro experiments have demonstrated that tau filaments
have the ability to seed, propagate, and diversify and that conformational barriers can
determine isoform recruitment. Our experiments suggest that the initial nucleation event
may have a profound effect on subsequent filament formation. Nuclei that contain 3R and
4R tau could establish templates that recruit all isoforms. Such a type of recruitment
could be important in AD where all isoforms are deposited (Goedert et al., 1992a). Nuclei
that contain only 4R tau could establish templates that recruit only 4R tau. Importantly,
such a conformational barrier could explain the preferential deposition of 4R tau in
progressive supranuclear palsy, corticobasal degeneration, and other 4R tauopathies.
Although our in vitro experiments do not explain the preferential deposition of 3R tau in
Pick’s disease, it is possible that inefficient growth of 4R tau onto 3R tau seeds leaves
these filaments prone to cellular clearance. Alternatively, an additional type of 3R tau
filament may exist that is conformationally incompatible with 4R tau. Despite this lack of
understanding, the molecular mechanisms that explain strain diversity, transmission
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barriers, and strain emergence in prion diseases are clearly inherent in tau, suggesting that
similar phenomena might exist in tauopathies.
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Chapter Four: Study of Tau Conformers by DEER

4.1 Introduction
Amyloid fibrils may show polymorphism by (1) distinct modes of lateral
association of protofilaments without significant variation in molecular structure
(Jiménez et al., 2002) or (2) distinct morphologies can also result from significant
variations in molecular structure at the protofilament level (Petkova et al., 2005). Studies
in the previous chapter have shown that the seeds of K18 (4R) can recruit only 4R
monomers while the seeds of K19 (3R) can recruit both 3R and 4R monomers. The 4R
monomers do grow on K19 seeds albeit in slower manner when compared to the growth
of 3R monomers on K19 seeds (3R). The conclusion of the study was that the 3R seeds
were able to conformationally template 4R monomers. To study these conformationally
different tau filaments at the molecular level, PELDOR or DEER (double electronelectron resonance spectroscopy) was utilized.
4.1.1 Double electron-electron resonance spectroscopy.
Solid state NMR has been used to study the structures of fibrils at the molecular
level. Recent work in solid state NMR has demonstrated the feasibility of estimating
electron-nucleus distances in proteins in the 1–2 nm range (Helmus, et al., 2008; Tycko,
2011) while DEER in favorable cases can measure up to 6 nm in proteins (Dockter et al.,
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2009; Jeschke et al., 2005; Pannier, et al., 2000). Therefore when compared to solid state
NMR, DEER is a better technique to pick up long range distance changes which could be
a better reflection of structural changes in filaments.
DEER is a similar technique to Forster resonance energy transfer (FRET) (Yan, et
al 2003). For protein – protein interaction studies by both FRET and DEER, the target
molecules are labeled with pairs of fluorescent and paramagnetic labels respectively. The
distances measured between the labels reflect conformational differences between
proteins (Jeschke & Polyhach, 2007). Even though FRET is more sensitive than DEER
(Banham et al., 2006), it requires large chromophores, which must be chosen according
to the expected distance. Contrarily, DEER distance measurements can be performed
between identical much smaller nitroxide labels and are precise over a broader range of
distances (Jeschke, 2002; Jeschke et al., 2004). The CW EPR can also be used to measure
distances between two nitroxide labels (Altenbach et al., 2001), but above 2 nm it is not
very reliable (Berliner, 2000). Therefore above 2 nm, four pulse DEER is used (Milov et
al., 1981; Pannier et al., 2000) .
Previously DEER spectroscopy has been applied for structural characterization of
biomacromolecules such as membrane proteins (Dockter et al., 2009; Endeward et al.,
2009; Jeschke et al., 2005), DNA (Ward et al., 2007) and RNA (Schiemann & Prisner,
2007; Schiemann, 2009). Distance measurements using DEER have also been done in
filaments of α-synuclein (Karyagina et al., 2011) and hIAPP (human Islet Amyloid
peptide) (Bedrood et al., 2011).
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Here DEER in conjunction with SDSL was used to study the conformation of
filaments. In the technique, SDSL is done with nitroxide labels and these labels are used
for distance measurements. The observed distances are between the unpaired electrons at
the end of the spin labels (Jeschke et al., 2006; Schiemann, 2009).
4.1.2 DEER measurements.
DEER measurements are based on alteration of the magnetic dipole-dipole
interaction between two nitroxide spin labels by microwave pulses. Microwave pulses are
used at two different frequencies, the observation frequency (νobserve) excites a set of spins
in the EPR spectrum (spins X), and creates a spin echo signal. At the pumping frequency
(νpump) a pulse excites another set of spins (spins Y), which alternates the sign of dipoledipole interaction between spins X and Y. Hence the electron spin echo signal (DEER
signal) depends on the magnitude of dipole-dipole interaction between X and Y spins and
on pumping pulse time position and intensity (Fajer et al., 2007). The four pulse echo
sequence which was used for DEER measurement is shown in Figure 4.1.
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Figure 4.1: Four-pulse DEER sequence. A Hahn echo (dashed purple) is produced by a
π/2 pulse followed by a π pulse at the observer frequency (νobserve). This echo is again
refocused with a π pulse (purple). After the first observer π pulse, another set of spins are
excited at pump frequency (νpump), at time t’ (blue arrow). The τ1 and τ2 are kept constant
while t’ is sequentially stepped. When the two spins are coupled, stepping the pump pulse
causes oscillation of the amplitude of refocused echo. The frequency of the oscillation is
the dipolar coupling between both the spins.
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The DEER signal V(t) contains contributions from the interaction between the two
spins in one molecule but also from the interaction between spins on different molecules
and is thus considered a product of two contributions
V(t) = V(t)intra V(t)inter
V(t)inter describes the decay due to the intermolecular interactions of unpaired spins and
V(t)intra describes the periodic oscillations generated by the intramolecular interactions of
pairs of spins (Milov et al., 1984; Schiemann, 2009). For the experiments in this study,
intermolecular interactions were reduced by diluting the sample with protein that does not
contain paramagnetic labels.
The pairwise dipole-dipole coupling between two spins is the basis for distance
determination in DEER measurements. In the case of disordered system, the electron
electron coupling (

) is given by the sum of dipole dipole coupling (



) and the

exchange coupling J. In systems for which the point-dipole approximation is valid and for
which the exchange coupling J can be assumed to be isotropic
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Where gA and gB are the g values of the two spins, µ B is the Bohr magneton, µ 0 is
the permeability of free space, h is the Planck constant, r is the distance between the two
spins and θ is the angle between the static field axis and the axis connecting the loci of
the two electron spins. The distance measurement is based on the dependence of dipoledipole couplings on the inverse cube of the distance.
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To study the conformational differences between tau filaments, DEER
measurements were compared for double mutants of K18 grown on K18 seeds, K19
grown on K19 seeds and K18 grown on K19 seeds.
4.2 Methods
4.2.1 Site directed mutagenesis, protein expression, and protein purification.
In the site directed mutagenesis, first a single cysteine was introduced as
mentioned in Chapter 2 section 2.1.1 and this single cysteine DNA was used as a
template to introduce another cysteine. As these double mutants were difficult to obtain,
miniprep plasmid purifications were performed to sort the correct size of the required tau
DNA. The correct DNA was transformed again in XL1Blue competent cells and then
midiprep plasmid purifications were carried out to get higher yield for DNA sequencing.
Then protein expression and purification were performed as mentioned in chapter 2.
4.2.2 Multistep production of seeds.
In the initial step, filaments were formed by mixing 25 µM of cysteine free K18
with 50 µM of heparin (average molecular mass of 5000 Da, Celsus, Cincinnati, OH)
using elution buffer. After three days of agitation at 25°C, the filament sample was
chilled and sonicated for 20 seconds to create seeds using Fisher Scientific Sonifier (150
T Series). The next round of filament reaction was set up by adding 10% seeds (from the
first reaction) to 25 µM of K18 (cysteine free) and mixed with 50 µM of heparin.
Filaments formation was carried out at 37°C for 1 h. This procedure was repeated four
times and each time seeds from the previous reaction were used to form next set of
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filaments. The final seeds (4th cycle) were used in DEER sample preparation. The same
was done to prepare K19 (cysteine free) seeds.
4.2.3 Sample preparation for DEER experiments.
For the preparation of filaments for DEER measurement, the MTSL labeled
double mutant (procedure mentioned in chapter 2) was mixed with 50 fold excess of
cysteine free K18 or K19, 5% seeds from the 4th cycle of the multistep seeded reaction,
and heparin (protein:heparin molar ratio of 4:1). The final protein concentration was
50µM and fibrillization was carried out at 37°C. Before preparing the DEER sample, the
efficacy of seeds was checked by running a control acrylodan assay with and without
seeds as mentioned in chapter 3. For the acrylodan assay, the reaction conditions were
similar to those used for preparation of DEER sample. After 14 hrs, the formed filaments
were pelleted at 100,000 x g and washed once with elution buffer. To the filament pellets,
20-50 µl of elution buffer was added to reconstitute the sample, which was then pelleted
into a quartz capillary (1.1 mm inner diameter x 1.6 mm outer diameter) at 1000 x g. The
buffer layer in the capillary tube above the sedimented filaments was completely
aspirated out using a syringe. The capillary tube was flash frozen in liquid N2 and stored
at -80°C. DEER measurements were performed within seven days of making the sample.
4.2.4 Negative stain electron microscopy.
The EM grids of tau filaments were prepared as mentioned in chapter 2. The tau
filament concentration used was 5 µM.
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4.2.5 Setting up filaments of double mutants to confirm β parallel in-register
structure.

Samples for CW EPR measurement for completely labeled K18 and K19 double
mutants were spin labeled as described in chapter 2. Protein concentrations used were
~25µM. Filaments were prepared under agitation condition by mixing protein with
heparin at a molar ratio of 4:1 and by incubating at 25°C for 3 days. Samples were
pelleted at 100,000 x g for 30 minutes, washed with elution buffer, and transferred into
borosilicate capillaries (0.6 mm inner diameter x 0.84 mm outer diameter).
4.2.6 EPR and DEER measurements
CW EPR measurements of samples were recorded with a Bruker EMX
spectrometer fitted with an ER 4119HS resonator. Parameters for taking EPR spectrum
are mentioned in chapter 2 section 2.2.5. Spectra were normalized to the same number of
spins using double integration. From all spectra, a minor background arising from 0.5%
soluble tau was subtracted.
DEER data were obtained at Q-band frequencies (34 GHz) with a Bruker Elexsys
E580 spectrometer equipped with a 1-watt amplifier, a Bruker ER 5107 Q-band dielectric
pulse resonator, and an Oxford CF 935 cryostat. Measurements were performed using
four-pulse DEER experiment: π/2(νobs) – τ1 – π(νobs) – t’ – π(νpump) – (τ1 + τ2 – t’) π(νobs) - τ2 – echo (Figure 4.1) (Pannier et al., 2000; Dockter et al., 2009; Jeschke et al.,
2005). For the experiment, the resonator was fully overcoupled (Q~100). All
measurements were performed at a temperature of 80 K. The observer π/2 and π pulse
lengths were optimized for each run and ranged from 30 - 40 ns and 60 – 80 ns
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respectively. A pump pulse length of 40 ns was used. The τ1 and τ2 were kept constant
and time t’ was varied. Data analysis was performed for dipolar evolution times t = t’ - τ1
> 0. The resonance magnetic field was set at the global maximum of the nitroxide EPR
spectrum and the pump frequency, νpump, was set to the centre of the resonator dip. The
observer frequency, νobserver, was 37 MHz higher than νpump and coincided with of the
center of the spectrum (Fajer et al., 2007) (Figure 4.2). The repetition time was
calculated for each run as 1.2 times the T1 relaxation time and 8-step phase cycling was
used. The total measurement time for each sample was between 48 – 72 hours.

Figure 4.2: Field swept echo detected EPRspectrum. The pump frequency (νpump) and
the observer frequency (νobserver) for nitroxide label in Q-band are shown for the double
mutant K18 311/328 on K18 seeds.
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4.2.7 DEER data analysis.
DEER data was analyzed using “DeerAnalysis2011” (Jeschke et al., 2006). The
program DeerAnalysis2011 can extract distance distributions from dead-time free pulse
ELDOR data (constant-time and variable-time pulse DEER).
Before distance distribution can be obtained from the dipolar evolution time, a
background correction has to be performed. A background correction is performed to
ensure that intermolecular distances are suppressed and only intramolecular distances are
taken into account to find the distance distribution in the protein.
4.2.7.1 Homogenous background correction.
The general background function in this model is:
B (t) = exp (-ktd/3)
Where k quantifies the density of the spins and d is the dimensionality of the
homogeneous distribution. The distribution is homogeneous in d= 3 dimensions for
proteins in solution and for membrane proteins it can be confined to d= 2 (Hilger et al.,
2005; Zou & Mchaourab, 2010). For the current study 3D homogeneous background
correction was used as it showed better background correction with singly labeled
mutants. After the background correction, distances were extracted from the dipolar
evolution curves using Tikhonov regularization (Jeschke et al., 2006; Jeschke &
Polyhach, 2007).
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4.2.7.2 Tikhonov regularization.
The data analysis was done by Tikhonov regularization which is a non biased
(model independent) way of finding the distance distribution (Jeschke et al., 2006;
Jeschke & Polyhach, 2007).
In Tikhonov regularization, the distance distribution is quantified by a
regularization parameter α which is a compromise between smoothness (artifact
suppression) and resolution of the distance distribution. The optimum distance
distributions P(r) are obtained by minimizing the sum of the functions η(α) andρ(α),
where η(α) is the square norm of the second derivative of P(r),which is a measure of
smoothness multiplied by the regularization parameter α and ρ(α) is the mean square
deviation between the simulated and experimental dipolar evolution time domain data.
The larger α, lesser noise artifacts are introduced but also causes broadening of peaks in
distance distribution. The optimum α is obtained by plotting log η(α) versus log ρ(α)
which quantifies the mean square deviation and the smoothness. The L-curve (shape of
the plot resembles alphabet “L”) for the data is implemented by doing Tikhonov
regularization for a given set of regularization parameters (Chiang, et al., 2005)
α = (0.001, 0.01, 0.1, 1, 10, 100, 1000, 10000, 100000).
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4.3 Results
4.3.1 Conformational templating of 4R on 3R seeds.
We showed previously in chapter 3 that 4R was able to grow on 3R seeds, while
3R was unable to grow on 4R seeds. To study the conformational differences between the
filaments when grown on different seeds, DEER was used. In this method double mutants
were created in the repeat region of the tau monomer which forms β parallel in-register
structure and is part of the core (Margittai & Langen, 2004) (chapter 2). The double
mutants 4R (K18-311/322, 311/326, 311/328) and 3R (K19-311/322, 311/326, 311/328)
were created by replacing amino acids at respective positions by cysteine residues
(K311C, 322-natural cysteine, G326C, I328C). To make sure that the replacement of
amino acids with cysteine residues in the double mutant did not disrupt the formation of
filaments, the double mutant monomers were labeled with MTSL and set for filament
formation. The measurement of filaments was performed using CW EPR, and single line
spectra were observed for all double mutants (Figure 4.3). This showed that the filaments
of the double mutant had formed parallel in-register structure (Margittai & Langen,
2008).
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Figure 4.3: EPR spectra of completely labeled double mutants with MTSL. 311/322,
311/326 and 311/328 double mutants of K18 and K19, EPR spectra were taken. Spectra
of all filaments were recorded at 150 G width and normalized to the same number of
spins.
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Next, samples for DEER were prepared by mixing 2% MTSL labeled double
mutant with cysteine free protein. As the growth of filaments was a seeded reaction,
seeds from the 4th cycle of multistep seeded reaction were used. Also, acrylodan assays
performed with the same parameters which were used to prepare DEER samples showed
the formation of filaments with the seeds of the 4th cycle from the multistep seeded
reaction. The filaments were pelleted by ultracentrifugation, taken up in EB, transferred
into quartz capillary and sedimented at 1000 x g. After this CW EPR measurements of
the sedimented filaments were taken. Spectral broadening of the EPR spectra was not
observed indicating that spin labeled monomers did not preferentially stack upon
themselves, but incorporated evenly into the filaments (Figure 4.4). Electron
micrographs of all the mutants confirmed the presence of filaments (Figure 4.5). The
DEER samples were flash frozen and DEER measurements were carried out for all the
samples, K18 311/322, K18 311/326, K18 311/328 on K18 and K19 seeds; K19 311/322,
K19 311/326, K19 311/328 on K19 seeds.
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Figure 4.4: EPR spectra of diluted double mutants. Spectra of double mutants,
311/322, 311/326 and 311/328 of K18 grown on K18 seeds (left column), K19 on K19
seeds (centre column) and K18 on K19 seeds. 2% of the labeled double mutant was
mixed with cysteine free tau protein. Spectra of filaments were recorded at 150 G scan
width and normalized to the same number of spins.
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A

B

C

Figure 4.5: Electron micrograph of filaments. Double mutants 311/322, 311/326 and
311/328 (A) K18 grown on K18 seeds (B) K19 grown on K19 seeds (C) K18 grown on
K19 seeds. Bar = 0.4 µm.
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The dipolar oscillation traces of K18 311/322 on K18 (truncated 4R) (black trace)
and K19 seeds (truncated 3R) (blue trace), K19 311/322 on K19WT seeds (red trace)
were obtained from DEER measurements (Figure 4.6 A). The dipolar oscillation traces
of these three different filament growths matched with each other. The dipolar oscillation
traces for 311/322 double mutant indicate similar spin-spin interactions for the three
types of filaments, K18 on K18, K19 on K19 and K18 on K19 seeds. Similar spin-spin
interactions between these double mutants indicate similar distances (Fajer et al., 2007).
Dipolar oscillation traces of K18 311/326 grown on K18 or K19 seeds and K19
311/326 grown on K19 seeds are shown in Figure 4.6 B. The results showed that when
K18 311/326 was grown on K19 seeds, the dipolar oscillation trace was closer to the
trace of K19 311/326 on K19 seeds rather than K18 311/326 grown on K18 seeds. The
spin-spin interactions between 311 and 326 of K18 311/326 on K19 seeds were closer to
that seen in K19 311/326 on K19 seeds. These results suggest that K18 311/326 on K19
seeds assumes a new conformation, similar to that of its seed. The same results were
obtained when K18 311/328 was grown on K19 seeds (Figure 4.6 C). Here, the spin-spin
interactions were not as strong as seen when K18 311/328 was grown on K18 seeds. The
weighted sum of the dipolar oscillation traces for singly labeled K19 for positions 311
and 326 (Figure 4.6 B, green trace) is similar to that of doubly labeled K19 311/326 and
K19 311/328. This indicates a longer interspin distance for K19 311/326 and K19
311/328 doubly labeled mutants on K19 seeds when compared to K18 on K18 seeds for
the same double mutant numbers. As a result, the data for 311/326 and 311/328 double
mutants suggest that when K18 monomers were grown on K19 seeds, the K18 filaments
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adopted the conformation of K19 seeds, which shows that K19 was able to
conformationally template K18.
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Figure 4.6: Dipolar oscillation curves of labeled mutants of tau filaments. (A)
Dipolar oscillation curves taken for a T2 of 2.5 µs. Double mutant 311/322 of K18
grown on K18 seeds (black), K19 grown on K19 seeds (red) and K18 grown on K19
seeds (blue). The curves for the three mutant filaments are the same. (B) Dipolar
oscillation curves of 311/326 mutant of K18 grown on K18 seeds, K19 grown on K19
seeds and K18 grown on K19 seeds. The weighted sum of the dipolar oscillation curves
for two singly labeled K19 311 and K19 326 is also shown (green). (C) The dipolar
oscillation curves of 311/328 of K18 on K18 seeds (black trace), K19 on K19 seeds (red
trace) and K18 on K19 seeds (blue trace).
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4.3.2 3R and 4R tau form heterogeneous filaments.
When the dipolar oscillation curves were fit using Tikhonov regularization to
obtain the distance distribution, multiple peaks suggest the presence of heterogeneous
filament mixtures. While closely spaced peaks could be the result of different rotamers,
peaks that are spaced over ~2.0-2.5 nm might represent different filament conformers.
4.3.2.1 Distance distribution for 4R double mutants.
The distance distributions between two spin labels in 4R were obtained by
Tikhonov regularization. Figure 4.7 A shows the dipolar evolution data after the 3D
homogeneous background correction (black trace) and the Tikhonov fit (red trace)
corresponding to the distance distribution for the double mutants K18 311/322, K18
311/326 and K18 311/328 grown on K18 seeds. The dipolar Pake pattern obtained from
the time trace after Fourier transformation is shown in Figure 4.7 B (black trace). After
Fourier transformation of the data after background correction, the dipolar spectrum has
the expected shape of a broadened Pake pattern and is well fitted by the dipolar spectrum
corresponding to the distance distribution using Tikhonov regularization (red trace)
(Figure 4.7 A, B) (Jeschke & Polyhach, 2007). The distance distributions when
Tikhonov regularization parameter α was set at 100 is shown in Figure 4.7 C. Distance
distributions in the K18 311/322 double mutant showed major component peaks at
distances of 3.4 nm and 3.9 nm with a distribution width of 1.6 nm. For K18 311/326, the
major component peak showed a distance of 3.6 nm with a distribution width of 1.2 nm
while a minor component peak was at 5 nm with a distribution width of 0.9 nm. In K18
311/328 on K18 seeds, the major component peak was at 4.8 nm with a width of 1 nm
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while minor component peaks were at 3.3 and 3.6 nm. The L-curves are also shown for
the three double mutants (Figure 4.8). The green marker in the L-curve highlights the
regularization parameter α = 100.
To make sure that the observed distance distributions were not due to noise
artifacts, for K18 311/328, Tikhonov fits were done at different scan numbers (Jeschke et
al., 2005; Jeschke et al., 2006). Here the minor peaks observed were 1/3rd of the major
peak. Even at lower scan numbers where the S/N is low, peaks were still seen at smaller
distances of 3.4 nm and 3.9 nm apart from 4.8 nm (data not shown) confirming the
formation of heterogeneous filaments. These results demonstrate that the Tikhonov
distributions of the double mutants showed multiple distance distributions showing
heterogeneity in the conformers of the filament mixture.
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Figure 4.7: Distance distribution for filaments of K18 double mutants on K18
seeds. (A) Dipolar evolution curve due to the double MTSL labels in the filament (black
trace), obtained by background correction, and the fit (red) corresponding to the distance
distribution. The data are plotted in stacks. (B) Dipolar spectrum obtained by Fourier
transformation of background corrected data (black) and fit to the spectrum
corresponding to the distance distribution. (C) Distance distributions obtained by
Tikhonov regularization with regularization parameter of α = 100. Maximum heights for
K18 311/322 = 3.4 and 3.9 nm, K18 311/326 = 3.6 nm and K18 311/328 = 3.4, 3.9 and
4.8 nm were observed.
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(C) K18 311/328 templated on K18 (4R) seeds. The green data point corresponds to the
regularization parameter α = 100 which was used to obtain the distance distribution.

98

4.3.2.2 Distance distribution of 3R double mutants.
Tikhonov regularization fit was done for the DEER data of K19 311/322
templated onto K19WT seeds (Figure 4.9). The L-curve is shown in Figure 4.11 A. In
the distance distribution, the major component peak was 3.9 nm and the width of this
distribution was 1.7 nm. For K19 311/326 and K19 311/328, we were unable to do
Tikhonov fits to obtain distance distributions from the dipolar evolution curves as the
spin-spin coupling was weak. As mentioned above, the dipolar oscillation traces of K19
311/326 and K19 311/328 on K19 seeds were closer to the traces of the weighted sum of
singly labeled K19 311 and K19 326. This clearly shows that the distance between the
two labels is large.
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Figure 4.9: Tikhonov regularization fit for double mutant K19311/322 templated on
K19 (3R) seeds. Dipolar evolution curves in time (A) and frequency (B) domains.
(C) Resulting distance distribution with a major peak at 3.8 nm. Black traces are after
background correction of the data while the red traces show fits after Tikhonov
regularization.
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4.3.2.3 Distance distribution of 4R double mutant on 3R seeds.
The Fourier transformed dipolar spectrum after 3D homogeneous background
correction (black trace), is well fitted by the dipolar spectrum corresponding to the
distance distribution using Tikhonov regularization (red trace) (Figure 4.10 A, B).
Tikhonov regularization fit for K18311/322 on K19 seeds showed major component peak
at 3.5nm with a width of 1.3 nm (Figure 4.10 C). The L-curve is shown in Figure 4.11 B
and the green marker in L-curve is at α = 100. The distance distribution obtained for
K8311/322 on K19 seeds was very similar to K19311/322 grown on K19 seeds and
different from K18311/322 grown on K18 seeds. Narrowing of the distance distribution
was seen when K18 was grown on K19 seeds. The distance distributions obtained when
K18 was grown on K18 seeds, K19 on K19 seeds and K18 on K19 seeds showed that the
mixture of filaments formed was heterogeneous.
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Figure 4.10: Tikhonov regularization fit for double mutant K18 311/322 templated
on K19WT seeds. The seeds were formed after five cycles of seeded reaction. (A)
Dipolar evolution curves in time and (B) frequency domains. (C) Resulting distance
distribution with a major peak at 3.5 nm. Black traces are after background correction of
the data while the red traces shows fits after Tikhonov regularization.
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4.4 Discussion
Structural information on the PHF fibril has been obtained by different
techniques, such as proteolysis, transmission electron microscopy (Goux, 2002; von
Bergen et al., 2006), CD, FTIR spectroscopy (Barghorn & Mandelkow, 2002; Frost et al.,
2009) and CW EPR (Margittai & Langen, 2004; Margittai & Langen, 2006a), but insight
into the structural arrangement of tau PHFs on the residue-specific level is still scarce.
DEER measurements have been used in these studies as a ‘spectroscopic ruler’ to
study conformational differences between various filaments (Jeschke et al., 2005).
Studies in this chapter have for the first time showed molecular level structural
differences in tau filaments using DEER measurements. For these experiments three
different cysteine double mutants were created in K18 and K19 in the 3rd repeat region of
the tau monomer. The 3rd repeat region is part of the core which forms the β parallel inregister structure in filaments. The intramolecular distances were defined by labeling the
two cysteine residues in each double mutant by a nitroxide label and the distance
measured was between two electrons localized in the N-O bond of the nitroxides
(Schiemann, 2009). Variations in the intramolecular distances between filaments suggest
differences in conformations (Fajer et al., 2007). For conformational studies by DEER,
three different types of filaments growth were examined 1) growth of K18 monomers on
K18 seeds 2) growth of K19 monomers on K19 seeds and 3) growth of K18 monomers
on K19 seeds.
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Comparison of the dipolar oscillation curves of K18 (4R) on 4R seeds, K19 (3R)
on 3R seeds and K18 (4R) on 3R seeds of 311/322 double mutant showed that they were
very similar. For the double mutant 311/326, the dipolar oscillation curve of K18 (4R)
grown on K19 (3R) seeds was different from K18 (4R) grown on K18 (4R) seeds. The
dipolar oscillation curve of 4R on 3R seeds was closer to 3R grown on 3R seeds (Figure
4.6 B). This showed that in this region, the conformation of 4R grown on 3R seeds was
similar to that of 3R on 3R seeds. The 3R seeds were able to conformationally template
4R of 311/326 double mutant. Similar results were obtained for 311/328 double mutant
(Figure 4.6 C). DEER measurements confirmed the conformational templating of 4R on
3R at the molecular level.
The dipolar evolution data were fit using Tikhonov regularization which is an
unbiased way to fit data compared to other fitting programs available in DEER Analysis
2011(Jeschke et al., 2006). Homogeneous background correction to account for
intermolecular interactions was done using d=3 dimensions. This spatial background
correction was used for the double mutants because it showed better background
correction with singly labeled mutants. The obtained distance distributions by Tikhonov
regularization for the double mutants showed that the filaments formed were
heterogeneous in nature. For the K18 on K18 seeds, double mutant 311/322 showed
distance distribution from 2-5.3 nm with peaks at 3.4 and 3.9, 311/326 double mutant
showed a distance distribution from 2.2 -5.3 nm with peak at 3.6 nm and for 311/328, 25.3 distance distribution was observed with peaks at 3.4, 3.9 and 4.8 nm. For the
experiments, the seeds used for templating of the monomers were prepared by going
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through multiple steps of seeded reactions as it had already been shown that samples with
a homogeneous mixture of filaments could be prepared by repetitive seeded growth
(Paravastu et al., 2008). Distance distributions of samples showed that the mixture of the
double mutant formed were heterogeneous even after templating the double mutant onto
the seeds from the 4th cycle of the multistep seeded reaction. Since the distance
distributions observed were really broad, the actual distances may not be just because of
the rotamer conformation of the spin label alone (Jeschke et al., 2005). During analysis of
raw data using DEER Analysis 2011, smaller peaks at the base line could be seen which
might denote noise artifacts (Jeschke et al., 2004). As observed in the distance
distributions of double mutants, the smaller peaks in 311/322 and 311/326 double mutant
may be ignored (Dockter et al., 2009) (Figure 4.7 A, B). In the K18 311/328 double
mutant distance distribution, observed peaks at 3.4 nm and 3.9 nm are almost one 3rd of
the highest peak at 4.8 nm (Figure 4.7 C). To check whether the smaller peaks were
noise related, Tikhonov regularization fits were done at various scan numbers. The lower
scan numbers with lower S/N showed the same heterogeneous distribution. These broad
distributions may not be attributed to intermolecular interactions between nitroxide labels
of different strands. To avoid intermolecular interactions between spin labels only 2% of
the double mutant was labeled. As already mentioned, the interstrand distance between
two β-strands is 4.8 Å, and hypothetically if the double mutant was incorporated after
every 48th strand in the filament, the distance would be ~23nm which is much larger than
the distances measured.
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The distance distribution of K18 311/322 on K19 seeds was similar to K19
311/322 on K19 seeds than to K18 311/322 on K18 seeds. The distance distribution of
K19 311/326 on K19 seeds could not be obtained. The dipolar oscillation curve of K19
311/326 on K19 seeds mutant is similar to the dipolar oscillation curve of the weighted
sum of singly labeled 311 and 326. Hence, the distance between 311 and 326 in the K19
double mutant is more than 5.5 nm (Jeschke et al., 2006). When the Tikhonov
regularization fit for distance distribution was done for K18 311/326 on K19 seeds, peaks
were observed at 2.8 and 4 nm. When the dipolar oscillation curves were looked at in
Figure 4.6 B for K18 311 326 on K19 seeds, the curve was closer to K19 311 326 on
K19 seeds. This led to the conclusion that the maximum population of K18 311 326 on
K19 seeds has a conformation which is similar to K19 311 /326 on K19 seeds. Therefore,
the majority of conformers of K18 311/326 on K19 seeds have really long distances. For
the double mutant 311/328 (K18, K19) on K19 seeds, Tikhonov regularization fits could
not be done to obtain distance distribution. Here we may not exclude the presence of
distances larger than 5 nm, which would be suppressed by the background correction for
2.5 µs evolution time. All of the above obtained distance distributions by DEER have
shown that the filaments form heterogeneous mixture, K18 when grown on K19 looks
more like K19 on K19 seeds rather than K18 on K18 seeds. The results have also shown
that DEER could be a very good technique to study structural polymorphism in fibrils.
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Solid state NMR was first used to study molecular level polymorphism in βamyloid fibrils of AD (Petkova et al., 2005). Similar polymorphism now has been
documented by solid-state NMR for α-synuclein fibrils (Heise et al., 2005), amylin
(IAPP) fibrils (Madine et al., 2008) and other amyloid fibrils (Paravastu et al., 2006).
Previous studies on conformational templating differences between seeded
reactions in tau filaments at the structural level have been shown based on circular
dichroism spectroscopy (CD) and FTIR (Frost et al., 2009). These studies by CD and
FTIR showed differences based on the secondary structures (β-sheet, random coil, α-helix
and random coil) seen in tau filaments. Differences in the filament fragilities and
morphologies based on the electron microscopy also helped in studying the structural
differences. Though the mentioned studies have shown structural differences, the
differences were not as dramatic as shown by our DEER studies at molecular level.
Studies of structural polymorphism in tau filaments due to conformational
differences at the molecular level are important because it has been shown that in
sporadic tauopathies, phenotypic diversities are seen due to conformational differences in
wild type tau filaments (Frost et al., 2009; Legname et al., 2006; Tanaka et al., 2004b).
Also structural polymorphism has been seen in multiple amyloid forming proteins due to
formation of distinct conformers based on template conformation change (Petkova et al.,
2005; Yamaguchi et al., 2005).
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Evidence available in prion disease has suggested that there is a strong link
between the conformation of a fibrillar protein and the resultant phenotype (Bessen &
Marsh, 1994; Legname et al., 2006; Peretz et al., 2002). When prion monomers from one
species were cross-seeded with preformed fibrils from another species, a new amyloid
strain was produced which showed the secondary structure and morphology of the
template fibrils. Conformational differences which were strain-specific because of crossseeding were also found in yeast Sup35 prion amyloid fibrils by FTIR and EPR spectra
(Tanaka et al., 2005). It has also been suggested that prion populations comprised of
variety of conformers with the same sequence, constitutes ‘quasi-species’, from which
the one replicating most efficiently in a particular environment is selected. The transfer of
prions between cell types within the same species involves a selection of favored
‘substrains’, and propagation of prions in the presence of an inhibitory drug can result in
the appearance of drug-resistant prion populations (Weissmann et al., 2011).
A very recent study in mice has shown that the transfer of tau filaments between
synapses of neurons causes the spread of neurodegenerative disease (Liu et al., 2012).
We have shown in our study that there are innumerable number of compositionally
(Siddiqua & Margittai, 2010) and conformationally distinct filaments of tau (Dinkel et
al., 2011). There might be some species of tau conformers which might be more
infectious than the others as shown in prion populations and hence structural
polymorphism could be a major contributor to the diversity of tauopathies.
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Studies have also shown that in AD, the appearance of NFTs of tau correlates
really well with the symptoms of the disease, while the same is not seen with β-amyloid
plaques (Braak et al., 1994; Liu et al., 2012). Since most of the drugs which were
targeted at β-amyloid have failed (Medina, 2011), this research work on basic
understanding of tau filament structures is a stepping stone in coming up with better
treatments targeted at molecular clearances of the filaments (Cohen & Kelly, 2003). The
findings of our research in understanding structural polymorphism of tau filaments are
highly significant in the ongoing research in neurodegenerative diseases and their
treatments.
.
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Appendix A
RECIPES
NZY media
NaCl
MgSO4*7H2O
Bacto-yeast extract
NZ amine (casein
hydrolysate)
Total volume
pH

5g
2g
5g

10 g
1L
7.5

NZY+ media
NZY media
MgCl2
MgSO4
Glucose

12.5 mM
12.5 mM
20 mM

LB Media
LB Broth
Kanamycin
Total volume

25 g
30 mg
1.5L

Kanamycin-LB Agar plates
LB Broth
LB Agar
Kanamycin

20 g
15 g
50 mg

Total volume

1.0 L
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Extraction buffer
NaCl
PIPES (pH 6.5)
EDTA (pH 8.0)
Total volume

500 mM
20 mM
5 mM
1L

PIPES buffer
PIPES
pH
Total volume

302.37 g
6.5
1L

Conc. 1M

Buffer A for ion exchange
NaCl
PIPES (pH 6.5)
EDTA
DTT

50 mM
20 mM
0.5 mM
2 mM

Buffer B for ion exchange
NaCl
PIPES (pH 6.5)
EDTA
DTT

1000 mM
20 mM
0.5 mM
2 mM
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Gel Filtration buffer
NaCl
Tris (pH 7.0)
EDTA
DTT

100 mM
20 mM
1 mM
2 mM

SDS Running buffer
1X
Glycine
Tris base
SDS
Total volume

28.8 g
6.04 g
2g
2L

SDS-PAGE 4x Sample Buffer
Reagent
80% Glycerol
1M Tris-Cl, pH 6.8
SDS
Bromophenol blue
H2O

Final Concentration
40%
240 mM
8%
0.1%

Volume
5ml
2.4ml

Mass

0.8 g
4 mg
2.1ml

SDS-PAGE Gel buffers
4X Lower gel buffer

1.5 M Tris-Cl (pH 8.8)
0.4% SDS

4x Upper gel buffer

0.5 M Tris-Cl (pH 6.8)
0.4% SDS
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12% SDS PAGE Gel (For 2 Gels)

Acryl-Bisacrylamide
Tris-Cl (pH 6.8)
Tris-Cl (pH 8.8)
10 % SDS
dH2O
10% APS
TEMED

Separation Gel (Lower)(12%)
4 ml
2.5 ml
0.1 ml
3.4 ml
50 µl
5 µl

Stacking (Upper)(4%)
1.3
2.5
0.1
6.1
50 µl
10 µl

15% SDS PAGE Gel (For 2 Gels)

Acryl-Bisacrylamide
Tris-Cl (pH 6.8)
Tris-Cl (pH 8.8)
10 % SDS
dH2O
10% APS
TEMED

Separation Gel (Lower)(15%)
5 ml
2.5 ml
0.1 ml
2.4 ml
50 µl
5 µl

0.1
6.1
50 µl
10 µl

Coomassie blue stain solution
Coomassie blue
methanol
Acetic acid
dH2O

Stacking (Upper)(4%)
1.3
2.5

2.5 g
200 ml
50 ml
250 ml
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Destain solution
125 ml
50 ml
1L

Glacial Acetic acid
Methanol
Total volume

1X TBE buffer for Agarose Gel Electrophoresis
Tris base
Boric acid
EDTA

1M
1M
20 mM

HEPES Buffer
HEPES
pH
Total volume

260.28
7.4
1L

Conc. 1M

Elution Buffer (EB)
NaCl
HEPES (7.4 pH)
NaN3
Total volume

100 mM
10 mM
0.1 mM
1L
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Appendix B
Genscript QuickClean 5M PCR Purification Kit protocol of PCR product
purification purification
1. The PCR reaction sample was transferred to a 1.5 ml microcentrifuge tube and
400 µl of binding solution was added and thoroughly mixed.
2. The above mixture was transferred to a column and centrifuged at 12,000 rpm for
one minute.
3. The flow –through was discarded and 500 µl of wash solution was added to
column. The column was then centrifuged at 12,000 rpm for 30 seconds.
4. To remove the residual amount of wash solution, the column was centrifuged for
an additional one minute.
5. The column was transferred to a clean 1.5 ml microcentrifuge tube. To the centre
of the column membrane 30 µl of the elution buffer was added and incubated at
room temperature for one minute. To collect the DNA the column was
centrifuged again for one minute. The eluted DNA in the microcentrifuge tube
was stored at -20°C.
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Qiagen® Midiprep Plasmid Purification kit
1. For starter culture a single colony was picked for bacterial growth in LB medium
with 30 mM kanamycin and kept in the shaking incubator at 37°C for 17 hrs.
2. Bacterial cells were harvested at 6000 x g for 15 minutes at 4°C.
3. The bacterial pellet was resuspended in 4 ml Buffer P1.
4. To the resuspended bacterial pellet, 4 ml of Buffer P2 was added, mixed
thoroughly by vigorously inverting the sealed tube 4-6 times, and incubated at
room temperature (15-25°C) for 5 minutes
5. To the above mixture, 4 ml of chilled Buffer 3 was added and immediately mixed
by vigorously inverting 4-6 times. The sample was incubated on ice for 15
minutes.
6. After 15 minutes, the sample was centrifuged for 20,000 x g for 30 minutes at
4°C. The supernatant which has the plasmid DNA was removed immediately.
7. The supernatant was centrifuged again at 20,000 x g for 15 minutes at 4°C. The
supernatant containing the plasmid was removed promptly.
8. QIAGEN-tip 100 was equilibrated by applying 4 ml of Buffer QBT and allowed
the column to empty by gravity flow.
9. The supernatant from step 7 was applied to the QIAGEN-tip and allowed it to
enter the resin by gravity flow.
10. The QIAGEN-tip was washed 2 times with 10 ml Buffer QC.
11. The DNA was eluted with 5 ml of Buffer QF.
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12. The DNA was precipitated by adding 3.5 ml of isopropanol, mixed and
centrifuged immediately at 15,000 x g for 30 minutes at 4°C. After centrifugation
the supernatant was carefully decanted.
13. The DNA pellet was washed with 1.8 ml of room temperature 70% ethanol and
centrifuged at 15,000 x g for 10 minutes. The supernatant was carefully decanted
without disturbing the pellet.
14. The pellet was air dried and redissolved in TE buffer of pH 8.0.

GenScript Quickclean 5M Miniprep kit protocol for plasmid purification
1. For overnight culture a single colony was picked and put into a polypropylene
tube with 5 ml LB medium and 30 mM kanamycin and kept in the shaking
incubator at 37°C for 17 hrs for bacterial growth.
2. From the overnight culture, 1.5 ml was transferred to 1.5 ml microcentrifuge tube
and centrifuged at 12,000 rpm for 30 seconds. The supernatant was discarded.
This was continued until all the bacteria were pelleted from the overnight culture.
3. To the pellet 100 µl of solution I was added and the cells were resuspended. The
cells were resuspended by running the narrow end of the microcentrifuge tube
along an empty microcentrifuge storage rack.
4. To the mixture 200 µl of solution II was added. The solution was mixed gently by
inverting the tube 4-6 times.
5. After this 300 µl of solution III was added and mixed gently by inverting the tube
4-6 times.
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6. The sample was centrifuged at 12,000 rpm for five minutes and the supernatant
was transferred to the column. The column was centrifuged for 30 seconds at
12,000 rpm.
7. The flow through was discarded and 500 µl of the wash solution was added and
centrifuged for 30 seconds.
8. The flow through was discarded and the column was centrifuged for additional 60
seconds to remove the residual wash solution
9. The column was transferred to a clean 1.5 ml microcentrifuge tube. To the centre
of the column 30 µl of the elution buffer was added and allowed the column to
stand at room temperature for one minute. After one minute the column was
centrifuged at 12,000 rpm for one minute. The eluted sample which has the
plasmid DNA was stored at -20°C until further use.
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Appendix C
Protein concentration determination was done using the Lambert Beer’s law:
A Full length tau protein concentration determination was done at 280 nm:
A=εcl
Molar extinction coefficient of full length tau: 7395 mol-1Lcm-1, path length of the
cuvette = 1cm.
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Appendix D
Cation exchange method parameters
Mono S 10 GL 100 method on Unicorn 5.11 was used to purify proteins by ion exchange

Gradient segment 1

Gradient segment 2

Gradient segment 3
Gradient delay (ml)
Clean after elution (CV)

Flow rate (ml/min)
Column Pressure limit
(mPa)
Averaging time for UV
Fraction size (ml)
Target conc (%B)
Length of gradient (CV)
Fraction size (ml)
Target conc (%B)
Length of gradient (CV)
Fraction size
Target conc (%B)

Gel filtration parameters
Manual run was used in Unicorn 5.11.
5
5
0.8

Flow rate (ml/min)
Fraction size (ml)
Column Pressure limit (MPa)
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3
3
2.60
3
15
3
3
60
8
3
100
5
5

Appendix E
Protein concentration measurement by Pierce® BCA Protein Assay kit
1. Bovine serum albumin (BSA) standards were prepared from 2000 µg/ml to 62.5
µg/ml
2. Working reagent of BCA was prepared by mixing 50ml Reagent A with 1ml of
Reagent B
3. Test-tube Procedure in the protocol was used to find the concentration of the
unknown protein
4. 85 µl of each standard and unknown sample were pipetted in appropriately
labeled test tube
5. 1.7 ml of the working reagent was added to each tube and mixed well
6. The Standard Protocol was followed. The tubes were incubated for 30 minutes at
37°C.
7. All the tubes were cooled to room temperature
8. The absorbance of the samples was measured at 562 nm with water as the blank.
9. Standard curve was plotted and the protein concentration of the unknown was
determined.
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Appendix F
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